syndrome	score	normalized_score
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.005917759	100.0
JERVELL AND LANGE-NIELSEN SYNDROME	1.000541419	99.46552887133193
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0	99.41170548515986
BNAR SYNDROME	1.0	99.41170548515986
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	99.41170548515986
DEHYDRATED HEREDITARY STOMATOCYTOSIS	1.0	99.41170548515986
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	1.0	99.41170548515986
HEPARIN-INDUCED THROMBOCYTOPENIA	1.0	99.41170548515986
DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	0.5103093	50.73071783793808
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.5089540240000001	50.59598753937499
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.34722189999999997	34.51792126079762
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.33870933999999997	33.67167315315287
CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF	0.333333	33.13720202448479
ALCOHOL SENSITIVITY, ACUTE	0.333333	33.13720202448479
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	33.13720202448479
ALDEHYDE DEHYDROGENASE 2 FAMILY	0.333333	33.13720202448479
CONGENITAL ENTEROVIRUS INFECTION	0.25840336	25.68831872069574
TUBERCULOSIS	0.2535461	25.205450220110887
KAPOSI SARCOMA	0.2535461	25.205450220110887
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	24.852926371289964
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.25	24.852926371289964
WEST SYNDROME	0.25	24.852926371289964
PLACENTAL INSUFFICIENCY	0.25	24.852926371289964
HYPERTRICHOSIS CUBITI	0.25	24.852926371289964
TUBEROUS SCLEROSIS COMPLEX	0.242857	24.142828559009466
NON-FUNCTIONING PARAGANGLIOMA	0.2178317	21.655020805731695
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.2178317	21.655020805731695
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.2178317	21.655020805731695
CRI-DU-CHAT SYNDROME	0.20731031500000002	20.60907197881572
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424822	20.304663892508138
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.20099502500000002	19.981258229282346
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	19.882341097031972
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	19.882341097031972
TRANSALDOLASE DEFICIENCY	0.2	19.882341097031972
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	19.33003948486807
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	19.33003948486807
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	19.33003948486807
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	19.33003948486807
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	19.33003948486807
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	19.33003948486807
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	19.33003948486807
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.18118594999999998	18.012004299448897
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.16566834	16.469372224295327
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.161550445	16.060005259336513
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.15126960499999997	15.037969421116463
HEREDITARY FRUCTOSE INTOLERANCE	0.14696984899999996	14.610523343986412
PEROXISOME BIOGENESIS DISORDER 11B	0.1456475	14.479066374649822
ALPHA-MANNOSIDOSIS	0.143852025	14.30057514274385
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.14285699999999998	14.201658010493478
YELLOW NAIL SYNDROME	0.14285699999999998	14.201658010493478
GLOMUVENOUS MALFORMATION	0.14285699999999998	14.201658010493478
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.14285699999999998	14.201658010493478
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.1289808	12.822201302840309
MIRAGE SYNDROME; MIRAGE	0.12754929400000004	12.67989284996807
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.11835751900000002	11.766122820782215
CRYPTOSPORIDIOSIS	0.115873	11.519132549681927
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	11.045734008161595
AGEL AMYLOIDOSIS	0.10662252	10.599526556325566
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.1021692	10.156814420054394
NEUROLEPTIC MALIGNANT SYNDROME	0.10214751	10.154658180162421
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.10133491000000001	10.073876228285181
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.100995025	10.040087680766357
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.10079582000000001	10.020284371975185
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.1	9.941170548515986
IMMUNODEFICIENCY 15A; IMD15A	0.1	9.941170548515986
ILEAL NEUROENDOCRINE TUMOR	0.09808610000000001	9.750906485387938
JEJUNAL NEUROENDOCRINE TUMOR	0.09808610000000001	9.750906485387938
DOORS SYNDROME	0.09722439000000001	9.665242424654322
PMM2-CDG	0.096088859	9.55235735131305
CHOPS SYNDROME; CHOPS	0.09475525000000001	9.419781006172695
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.09145051900000001	9.091252061293016
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.09145051900000001	9.091252061293016
CLEFT VELUM	0.0909091	9.037428675120946
X-LINKED DYSTONIA-PARKINSONISM	0.0909091	9.037428675120946
MOHR-TRANEBJAERG SYNDROME	0.0909091	9.037428675120946
RHEUMATOID ARTHRITIS	0.0901315	8.960126132935686
PEDIATRIC-ONSET GRAVES DISEASE	0.08752427000000002	8.700936952043614
GRFOMA	0.08690473000000001	8.639347424027337
SLC35A2-CDG	0.086064605	8.555829164956616
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08387471900000001	8.338128862878543
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08387471900000001	8.338128862878543
PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN	0.08333330000000001	8.284305476706473
HYPERHIDROSIS PALMARIS ET PLANTARIS	0.08333330000000001	8.284305476706473
BOOK SYNDROME	0.08333330000000001	8.284305476706473
KERATOLYTIC WINTER ERYTHEMA; KWE	0.08333330000000001	8.284305476706473
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.08333330000000001	8.284305476706473
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.08333330000000001	8.284305476706473
LATE-ONSET JUNCTIONAL EPIDERMOLYSIS BULLOSA	0.08333330000000001	8.284305476706473
%164800 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5;;ONYCHOLYSIS, PARTIAL, WITH SCLERONYCHIA;;ONYCHOLYSIS, HEREDITARY DISTAL	0.08333330000000001	8.284305476706473
PACHYONYCHIA CONGENITA 2	0.08333330000000001	8.284305476706473
ADNP SYNDROME	0.082272169	8.1788166342533
KABUKI SYNDROME 1	0.081298374	8.082010012510379
PAROXYSMAL HEMICRANIA	0.08123252	8.075463354057359
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.07991309	7.944296567489073
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.079194085	7.872819054186715
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.07912091	7.865544602637839
FONTAINE PROGEROID SYNDROME; FPS	0.07843897500000001	7.797752281257818
GLUTAMATE MONOSODIUM SENSITIVITY	0.07680494000000002	7.635310075085375
BRUNNER SYNDROME; BRNRS	0.07680494000000002	7.635310075085375
LAFORA DISEASE	0.07680494000000002	7.635310075085375
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.075995055	7.554798025988525
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.075816169	7.537014663641106
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.07577529499999999	7.532951309591105
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.07527475000000002	7.483191277469039
DUBOWITZ SYNDROME	0.07460761	7.416869752271668
GAUCHER DISEASE, TYPE II	0.074139219	7.370306204127769
MARSHALL-SMITH SYNDROME; MRSHSS	0.072423625	7.1997560786676615
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.07158763	7.116648389940594
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.07148935399999999	7.1068786051723345
OCULOPHARYNGODISTAL MYOPATHY	0.07142860000000001	7.10083894641729
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.07142860000000001	7.10083894641729
FLUSHING OF EARS AND SOMNOLENCE	0.07142860000000001	7.10083894641729
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1	0.07142860000000001	7.10083894641729
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.07142860000000001	7.10083894641729
DERMODISTORTIVE URTICARIA	0.07142860000000001	7.10083894641729
OROFACIODIGITAL SYNDROME IX; OFD9	0.07142860000000001	7.10083894641729
PERICARDIAL EFFUSION, CHRONIC	0.07142860000000001	7.10083894641729
OROFACIODIGITAL SYNDROME VIII; OFD8	0.07142860000000001	7.10083894641729
PAROXYSMAL EXTREME PAIN DISORDER	0.07142860000000001	7.10083894641729
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.07142860000000001	7.10083894641729
PHELAN-MCDERMID SYNDROME	0.070653899	7.023824598766231
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.070053065	6.964094666112759
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.068693274	6.828915523699389
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.067711125	6.731278416568845
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.067341175	6.6945010561246105
ESOPHAGEAL ATRESIA	0.067341175	6.6945010561246105
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.06634615	6.595583923874239
PONTINE TEGMENTAL CAP DYSPLASIA	0.066205644	6.58161598278334
MARFAN SYNDROME	0.06442909499999999	6.4050062168153845
TAY-SACHS DISEASE; TSD	0.063041419	6.267054978994562
GM2-GANGLIOSIDOSIS, AB VARIANT	0.063041419	6.267054978994562
FLYNN-AIRD SYNDROME	0.06282908400000001	6.245946394510369
COWDEN SYNDROME	0.06282908400000001	6.245946394510369
CLEFT LARYNX, POSTERIORSTRIDOR, CONGENITAL, INCLUDED	0.0625	6.213231592822491
HYPEREKPLEXIA 1; HKPX1	0.0625	6.213231592822491
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.0625	6.213231592822491
SPINOCEREBELLAR ATAXIA TYPE 8	0.0625	6.213231592822491
SPERMATOGENIC FAILURE 15; SPGF15	0.0625	6.213231592822491
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0625	6.213231592822491
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.0625	6.213231592822491
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.0625	6.213231592822491
SARCOIDOSIS	0.0623696	6.200268306427226
NEUROFIBROMATOSIS TYPE 1	0.061124684	6.076509083681462
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.060359944	6.0004849760287415
LOEYS-DIETZ SYNDROME 3; LDS3	0.060249145000000004	5.989470258472692
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.059364919	5.901567843778371
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.059364919	5.901567843778371
NASU-HAKOLA DISEASE	0.059364919	5.901567843778371
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.0588235	5.847744457606301
WILD TYPE ABETA2M AMYLOIDOSIS	0.0588235	5.847744457606301
TRISOMY 8Q	0.0588235	5.847744457606301
CHERUBISM	0.0588235	5.847744457606301
INFANTILE MYOFIBROMATOSIS	0.0588235	5.847744457606301
MYCETOMA	0.0588235	5.847744457606301
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.0588235	5.847744457606301
SAPHO SYNDROME	0.05639556	5.606378801390662
GLUCAGONOMA	0.05620303	5.587239065733604
SHEEHAN SYNDROME	0.05620303	5.587239065733604
SOMATOSTATINOMA	0.05620303	5.587239065733604
19P13.3 MICRODUPLICATION SYNDROME	0.05534122	5.501565063829439
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.05528886	5.496359866930235
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.05525842	5.493333774615268
HYPOPLASMINOGENEMIA	0.0545894	5.426825355411586
FASCIAL DYSTROPHY, CONGENITAL	0.0545894	5.426825355411586
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.05422606	5.390705106340608
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.053881229	5.356424868526455
144120 HYPERIMMUNOGLOBULIN G1(A1) SYNDROMEIMMUNOGLOBULIN HEAVY CHAIN REGULATOR, INCLUDED; IGHR	0.0526316	5.232197118412739
JUVENILE POLYPOSIS SYNDROME	0.0526316	5.232197118412739
VIPOMA	0.0526316	5.232197118412739
AUTOIMMUNE HEPATITIS	0.0526316	5.232197118412739
FAMILIAL PANCREATIC CARCINOMA	0.0526316	5.232197118412739
ADENOCARCINOMA OF THE ANAL CANAL	0.0526316	5.232197118412739
LARYNGEAL NEUROENDOCRINE TUMOR	0.0526316	5.232197118412739
GALLBLADDER NEUROENDOCRINE TUMOR	0.0526316	5.232197118412739
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.0526316	5.232197118412739
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.052367284	5.205921014065724
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0517242	5.141990936855505
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0517242	5.141990936855505
SANDIFER SYNDROME	0.05146985	5.1167055695653545
PALLISTER-KILLIAN SYNDROME	0.049971858999999993	4.967787729453934
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.049888699999999994	4.959520751437494
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.04954201900000001	4.925056601968195
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.04954201900000001	4.925056601968195
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.04930065	4.901061698026946
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.04921893000000001	4.892937773454699
ALG11-CDG	0.049160144	4.887093756936048
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.048586174	4.830034420338731
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.048371700000000004	4.808713194216507
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.047865869000000005	4.758427671819244
CONGENITAL MYASTHENIC SYNDROME	0.047865869000000005	4.758427671819244
ARACHNOIDITIS	0.04783282	4.755142214364664
ADENOCARCINOMA OF OVARY	0.047623700000000005	4.734353238513608
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.047623700000000005	4.734353238513608
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.047049730000000005	4.677293901916291
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.047049730000000005	4.677293901916291
DISTAL TRISOMY 17Q	0.04699094400000001	4.6714498853976405
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.046188919	4.591719212305905
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.046147	4.587551973023672
MERCURY POISONING	0.045995919	4.572532753147269
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.045995919	4.572532753147269
GLYCEROL KINASE DEFICIENCY; GKD	0.045995919	4.572532753147269
WHITE FORELOCK WITH MALFORMATIONS	0.045947440000000006	4.567713373077053
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	4.554328581050531
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.04564750000000001	4.537895826133835
DUODENAL NEUROENDOCRINE TUMOR	0.0454545	4.518709366975199
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0454545	4.518709366975199
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.0454545	4.518709366975199
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0454545	4.518709366975199
PRADER-WILLI SYNDROME	0.04501474400000001	4.474992473017868
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.0447921	4.452859053261829
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0447921	4.452859053261829
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.0447921	4.452859053261829
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.0447921	4.452859053261829
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.04447332500000001	4.421169086845798
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.044019719000000006	4.376075340767496
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.044019719000000006	4.376075340767496
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.044019719000000006	4.376075340767496
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.044019719000000006	4.376075340767496
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	4.376075340767496
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.044019719000000006	4.376075340767496
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0438464	4.358845403384513
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0438359	4.357801580476918
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	4.322251954595426
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.043478300000000004	4.322251954595426
GLYCINE ENCEPHALOPATHY	0.043478300000000004	4.322251954595426
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	4.322251954595426
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	4.322251954595426
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	4.322251954595426
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	4.322251954595426
JUVENILE XANTHOGRANULOMA	0.043478300000000004	4.322251954595426
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	4.322251954595426
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	4.322251954595426
LICHTENSTEIN SYNDROME	0.043478300000000004	4.322251954595426
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.043478300000000004	4.322251954595426
HYDROXYKYNURENINURIA	0.043478300000000004	4.322251954595426
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	4.322251954595426
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	4.322251954595426
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	4.322251954595426
HYPOTONIA-CYSTINURIA SYNDROME	0.043478300000000004	4.322251954595426
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.043288679000000004	4.303401407589624
SHORT SYNDROME	0.042992039999999995	4.273912018686212
LIMB-MAMMARY SYNDROME	0.0425674	4.231697832068993
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.041692059999999996	4.144678789789613
MYCOSIS FUNGOIDES	0.041692059999999996	4.144678789789613
BULLOUS PEMPHIGOID	0.041692059999999996	4.144678789789613
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.041692059999999996	4.144678789789613
CLASSICAL EHLERS-DANLOS SYNDROME	0.04127402499999999	4.103121217487124
H SYNDROME	0.04052256	4.028416800224719
NORRIE DISEASE	0.039911764	3.967696528161206
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.039375629999999995	3.9143985328526245
CASPASE 8 DEFICIENCY	0.03919586	3.8965272905575574
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0388807	3.8651966974568546
SUBEPENDYMOMA	0.038123139	3.7898862664378115
EPENDYMOMA	0.038123139	3.7898862664378115
PURE AUTONOMIC FAILURE	0.03805423	3.783035905224535
GALLOWAY-MOWAT SYNDROME	0.037516179	3.7295473376765385
SCALP-EAR-NIPPLE SYNDROME	0.036805	3.6588478203813084
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.03679922499999999	3.658273717782131
WISKOTT-ALDRICH SYNDROME	0.03547557999999999	3.5266879108752267
CLUSTER HEADACHE, FAMILIAL	0.03547011	3.526144128846223
BUERGER DISEASE	0.03547011	3.526144128846223
TUFTED ANGIOMA	0.03547011	3.526144128846223
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.035375870000000004	3.5167755697213026
COCKAYNE SYNDROME A; CSA	0.035024219	3.4818173440757403
SMITH-MAGENIS SYNDROME; SMS	0.034519674	3.4316596651317304
VAN DEN BOSCH SYNDROME	0.0344828	3.4279939579036705
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.0344828	3.4279939579036705
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	0.0344828	3.4279939579036705
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0344828	3.4279939579036705
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.0344828	3.4279939579036705
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.0344828	3.4279939579036705
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.0344828	3.4279939579036705
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0344828	3.4279939579036705
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.0344828	3.4279939579036705
ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD	0.0344828	3.4279939579036705
FAMILIAL DYSAUTONOMIA	0.034117804	3.3917090830484087
SANDHOFF DISEASE	0.03387461	3.367532752744651
X-LINKED AGAMMAGLOBULINEMIA	0.033503599999999994	3.3306500158926013
CHARGE SYNDROME	0.033412575	3.3216010654008152
SPINOCEREBELLAR ATAXIA TYPE 42	0.033253124999999994	3.305749868961206
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.032983229999999995	3.278919146709289
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.032799519	3.2606561228829047
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.032799519	3.2606561228829047
C SYNDROME	0.032684249	3.2491969355916304
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.032576984	3.238533539002765
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0322581	3.206832736710835
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.0322581	3.206832736710835
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.0322581	3.206832736710835
LIG4 SYNDROME	0.0322581	3.206832736710835
JUVENILE IDIOPATHIC ARTHRITIS	0.0322581	3.206832736710835
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0322581	3.206832736710835
PSORIASIS 2; PSORS2	0.0322581	3.206832736710835
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.0322581	3.206832736710835
PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15	0.0322581	3.206832736710835
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.0322581	3.206832736710835
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.0322581	3.206832736710835
IMMUNODEFICIENCY, COMMON VARIABLE, 14; CVID14	0.0322581	3.206832736710835
INTERMEDIATE UVEITIS	0.0322581	3.206832736710835
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.0322581	3.206832736710835
PSORIASIS 1, SUSCEPTIBILITY TO	0.0322581	3.206832736710835
PSORIASIS 14, PUSTULAR	0.0322581	3.206832736710835
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.0322581	3.206832736710835
PROPIONIC ACIDEMIA	0.03214283	3.1953735494195605
SCHWARTZ-JAMPEL SYNDROME	0.032035565	3.184710152830695
ROIFMAN SYNDROME; RFMN	0.03192182	3.173402568390285
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.031677315	3.1490959093406365
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.031581	3.139521070926833
POEMS SYNDROME	0.0313239	3.113962321446599
AMYOTROPHIC LATERAL SCLEROSIS	0.0313239	3.113962321446599
SEVERE COMBINED IMMUNODEFICIENCY	0.031257599999999996	3.1073713253729323
DOWN SYNDROME	0.03104054	3.085793020580324
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.030406825	3.0227943316387957
MICROSPORIDIOSIS	0.030303319000000002	3.012504623650849
RETINAL CAPILLARY MALFORMATION	0.03024694	3.006899891107301
22Q11.2 MICRODUPLICATION SYNDROME	0.030107844	2.9930721205211372
SOTOS SYNDROME	0.030107844	2.9930721205211372
NIJMEGEN BREAKAGE SYNDROME	0.029957499999999998	2.978126167071676
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.029957499999999998	2.978126167071676
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.029957499999999998	2.978126167071676
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.029953219	2.9777005855604943
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.029947	2.9770823441640824
LEUKOCYTE ADHESION DEFICIENCY	0.029814919000000002	2.9639519466918967
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.0297619	2.958681237478779
OMENN SYNDROME	0.0297619	2.958681237478779
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.0297619	2.958681237478779
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.029566425	2.9392487343490674
NIJMEGEN BREAKAGE SYNDROME	0.029469099999999998	2.9295734901127237
FELTY SYNDROME	0.029469099999999998	2.9295734901127237
MONOMELIC AMYOTROPHY	0.0294118	2.9238771993884245
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	2.9238771993884245
ECHO VIRUS 11 SENSITIVITY	0.0294118	2.9238771993884245
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	2.9238771993884245
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	2.9238771993884245
AMYLOIDOSIS	0.0294118	2.9238771993884245
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	2.9238771993884245
NAVAJO NEUROHEPATOPATHY	0.0294118	2.9238771993884245
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	2.9238771993884245
MYASTHENIA GRAVIS; MG	0.0294118	2.9238771993884245
TRICHOHEPATOENTERIC SYNDROME 1	0.0294118	2.9238771993884245
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	2.9238771993884245
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	2.9238771993884245
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	2.9238771993884245
MYELOPEROXIDASE DEFICIENCY	0.0294118	2.9238771993884245
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	2.9238771993884245
RAGWEED SENSITIVITY	0.0294118	2.9238771993884245
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	2.9238771993884245
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	2.9238771993884245
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	2.9238771993884245
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	2.9238771993884245
IMMUNE SUPPRESSION	0.0294118	2.9238771993884245
DUBOWITZ SYNDROME	0.029312544	2.9140099911487893
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0292735	2.9101285605198273
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.029190454	2.9018728160261067
DISTAL MONOSOMY 7Q36	0.029112819	2.894154988270766
CONGENITAL DISORDER OF GLYCOSYLATION	0.029112819	2.894154988270766
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.029112819	2.894154988270766
COFS SYNDROME	0.029112819	2.894154988270766
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029112819	2.894154988270766
ALG1-CDG	0.029112819	2.894154988270766
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.028897688999999997	2.872768548069743
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.028772825000000002	2.860355604876045
ALPHA-THALASSEMIA	0.0285714	2.840331602098696
TETRASOMY X	0.0285714	2.840331602098696
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	2.840331602098696
PENTASOMY X	0.0285714	2.840331602098696
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	2.840331602098696
COG7-CDG	0.0285714	2.840331602098696
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	2.840331602098696
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	2.840331602098696
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	2.840331602098696
CHEILITIS GLANDULARIS	0.0285714	2.840331602098696
ALG12-CDG	0.0285714	2.840331602098696
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	2.840331602098696
ACRODYSOSTOSIS	0.0285714	2.840331602098696
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	2.840331602098696
CONGENITAL LOBAR EMPHYSEMA	0.0285714	2.840331602098696
FETAL ALCOHOL SYNDROME	0.0285714	2.840331602098696
ERYTHERMALGIA, PRIMARY	0.028505139999999998	2.8337445824932495
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	2.818570379767995
BAZEX SYNDROME; BZX	0.02807659	2.791141696107584
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.027777800000000002	2.7614384726256738
THYROID LYMPHOMA	0.027777800000000002	2.7614384726256738
ACATALASEMIA	0.027777800000000002	2.7614384726256738
INFANTILE DIGITAL FIBROMATOSIS	0.027777800000000002	2.7614384726256738
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.027777800000000002	2.7614384726256738
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.027777800000000002	2.7614384726256738
INTERSTITIAL CYSTITIS	0.027777800000000002	2.7614384726256738
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.027777800000000002	2.7614384726256738
SPINOCEREBELLAR ATAXIA TYPE 43	0.027777800000000002	2.7614384726256738
HEREDITARY PAINFUL CALLOSITIES	0.027777800000000002	2.7614384726256738
FIBULAR HEMIMELIA	0.027777800000000002	2.7614384726256738
PRIMARY HYPEROXALURIA TYPE 3	0.027777800000000002	2.7614384726256738
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.027777800000000002	2.7614384726256738
OROMANDIBULAR DYSTONIA	0.027777800000000002	2.7614384726256738
EPIDERMAL NEVUS SYNDROME	0.027777800000000002	2.7614384726256738
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.027777800000000002	2.7614384726256738
VULVOVAGINAL GINGIVAL SYNDROME	0.027777800000000002	2.7614384726256738
OSTEOSARCOMA	0.027777800000000002	2.7614384726256738
O'SULLIVAN-MCLEOD SYNDROME	0.027777800000000002	2.7614384726256738
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.027777800000000002	2.7614384726256738
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.027777800000000002	2.7614384726256738
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.027777800000000002	2.7614384726256738
ANAPLASTIC THYROID CARCINOMA	0.027777800000000002	2.7614384726256738
STÜVE-WIEDEMANN SYNDROME	0.027261095	2.7100719473429637
OCCIPITAL HORN SYNDROME	0.026848294999999998	2.66903479531869
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.026723718999999996	2.65665048269617
SILVER-RUSSELL SYNDROME	0.026677475000000003	2.6520532877877154
INFANTILE SYSTEMIC HYALINOSIS	0.026306659999999996	2.615189936218235
WILLIAMS SYNDROME	0.026266345000000003	2.6111821533116015
AICARDI SYNDROME; AIC	0.026190625	2.6036546989722646
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.025848378999999998	2.5696314404167904
CUTIS LAXA	0.025813585	2.5661725095361403
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.025812739	2.5660884072333
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.025796318999999998	2.564456067029233
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.025492059999999997	2.534209160930024
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.025306959999999996	2.515808054244721
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0251956	2.504737566721894
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.025054904	2.4907507374069535
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.024935218999999998	2.478852647435962
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.024923018999999998	2.477639824629043
VASCULAR EHLERS-DANLOS SYNDROME	0.0248298	2.468372764855422
IMMUNODEFICIENCY 50; IMD50	0.02481856	2.467255377285769
CADASIL	0.024429839000000002	2.4286119597178724
611961 STEVENSON-CAREY SYNDROME	0.024338624	2.419544121002043
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.024329378999999998	2.418625059784833
TETRASOMY 9P	0.024110458999999997	2.3968618492200213
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.024059879	2.3918336051565823
CUSHING DISEASE	0.02380942	2.3669350488124747
16P13.2 MICRODELETION SYNDROME	0.023724733999999997	2.3585162691217585
VESICOURETERAL REFLUX 8; VUR8	0.023717929999999998	2.357839871877637
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.02364906	2.3509933877208744
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.02356531	2.342667657386492
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.02356531	2.342667657386492
ROIFMAN SYNDROME	0.023518459999999998	2.3380102189845124
HALLERMANN-STREIFF SYNDROME; HSS	0.023412855	2.327511845826752
NOCARDIOSIS	0.023352759	2.321537599973916
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.02332286	2.3185652893916155
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.02332286	2.3185652893916155
SCLERODERMA	0.023318269	2.3181088902517333
OSTEOGENESIS IMPERFECTA, TYPE I	0.02322031	2.3083706189941124
EHLERS-DANLOS SYNDROME, TYPE VI	0.02317616	2.3039815921969424
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.02307691	2.29411498042754
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.023038524	2.290298962700787
JACOBSEN SYNDROME	0.022945194	2.281020868227857
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.022883374999999997	2.2748753360064695
WILLIAMS-BEUREN SYNDROME; WBS	0.022802180000000002	2.2668036025796026
CRANIOECTODERMAL DYSPLASIA 4	0.02241783	2.228594713576381
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.02218829	2.2057757506993174
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.021762625	2.163459667083977
CINCA SYNDROME	0.02175338	2.162540605866767
CRISPONI SYNDROME	0.021707254	2.157955141539558
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.021661514	2.153408050130667
TAKAYASU ARTERITIS	0.021583749	2.1456772988536135
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.021309019000000002	2.1183659210056756
MIDDLE EAR NEUROENDOCRINE TUMOR	0.02124934	2.1124331298340264
SOMATOMAMMOTROPINOMA	0.02104233	2.091853912681544
ACROMEGALY	0.02104233	2.091853912681544
CLASSIC HODGKIN LYMPHOMA	0.02104233	2.091853912681544
EMANUEL SYNDROME	0.021000699	2.087715303970491
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.020912004	2.078897982752485
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0207875	2.0665208277727607
CORNELIA DE LANGE SYNDROME 1	0.020745608999999998	2.0623563720182814
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.020714174999999998	2.059231464468061
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.02054506	2.0424194538949383
MARFANOID HYPERMOBILITY SYNDROME	0.020439455000000002	2.031921080737178
LATERAL MENINGOCELE SYNDROME	0.020439455	2.031921080737178
PRIMARY CILIARY DYSKINESIA	0.020260265000000003	2.0141074972312927
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.02023643	2.0117380192310534
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.020169329	2.0050673943812933
MEIER-GORLIN SYNDROME 3; MGORS3	0.02009985	1.9981603684958902
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.020065124	1.9947081976112127
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.020055879	1.9937891363940023
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.01999787	1.9880223627705136
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01997254	1.9855042642705747
PRUNE BELLY SYNDROME	0.019951055	1.9833684037782258
TEMPLE SYNDROME	0.019900914999999998	1.9783839008651998
CRYPTOCOCCOSIS	0.019806659	1.9690137511529908
HEREDITARY FOLATE MALABSORPTION	0.019772169	1.9655850414308076
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.01974326	1.962711148436937
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.01974326	1.962711148436937
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0196671	1.9551399529471873
ADIPOSIS DOLOROSA	0.019657809000000002	1.9542163187915251
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.019594189999999997	1.947891845500264
WOLFRAM SYNDROME	0.019497449	1.9382746576999246
RIDDLE SYNDROME	0.01946084	1.9346352945738183
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.019419099999999998	1.9304858499868676
PYCNODYSOSTOSIS	0.01937556	1.9261574643300436
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.01937556	1.9261574643300436
KOOLEN-DE VRIES SYNDROME; KDVS	0.019303734	1.9190171191718668
TENORIO SYNDROME; TNORS	0.019271494	1.915812085787025
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.019192374	1.9079466316490397
BRITTLE CORNEA SYNDROME 2; BCS2	0.01906693	1.8954760296661588
HURLER SYNDROME	0.019037224999999998	1.8925230049547221
HENNEKAM-BEEMER SYNDROME	0.018971444	1.885983603556203
UROFACIAL SYNDROME 2	0.01895603	1.8844512715278545
OCHOA SYNDROME	0.01895603	1.8844512715278545
HINMAN SYNDROME	0.01895603	1.8844512715278545
UROFACIAL SYNDROME	0.01895603	1.8844512715278545
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.018913475	1.8802208064009336
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.018883558999999998	1.8772468058196397
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.018831499	1.8720714324320824
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.01871266	1.8602574447639315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.018583619	1.8474292588764207
PGM3-CDG	0.018472069	1.8363398831295514
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.018472069	1.8363398831295514
CUSHING SYNDROME	0.018433079999999998	1.83246392014439
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.018433079999999998	1.83246392014439
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.018236425	1.8129141112022062
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.018236425	1.8129141112022062
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.017968249	1.786254277672018
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.01785374	1.7748707426886179
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.01785374	1.7748707426886179
DERMATITIS HERPETIFORMIS	0.01769842	1.759430116592663
NOONAN SYNDROME 7; NS7	0.017562084	1.745876722313638
VON HIPPEL-LINDAU DISEASE	0.01749623	1.7393300638606186
LYNCH SYNDROME	0.017462869	1.736013589953928
FAMILIAL COLORECTAL CANCER TYPE X	0.017462869	1.736013589953928
INSULIN-RESISTANCE SYNDROME TYPE B	0.017435	1.7332430851337621
ISOLATED AGAMMAGLOBULINEMIA	0.017435	1.7332430851337621
MYXEDEMA	0.017426829999999997	1.732430891499948
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.01742499	1.732247973961856
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.01742499	1.732247973961856
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.017409444	1.7307025195883834
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.017287354	1.7185653444657005
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.017248725	1.7147251696945138
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.7139969789518352
SICKLE CELL ANEMIA	0.0172414	1.7139969789518352
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.7139969789518352
CARDIAC ARRHYTHMIA	0.0172414	1.7139969789518352
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.7139969789518352
TRANSSEXUALITY	0.0172414	1.7139969789518352
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.7139969789518352
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.7139969789518352
THUMBS, CONGENITAL CLASPED	0.0172414	1.7139969789518352
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	1.7139969789518352
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.7139969789518352
MYOPATHY, CONGENITAL	0.0172414	1.7139969789518352
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.7139969789518352
MOSAIC TRISOMY 15	0.0172414	1.7139969789518352
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.7139969789518352
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.7139969789518352
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	1.7139969789518352
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	1.7139969789518352
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.7139969789518352
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.7139969789518352
PALMOMENTAL REFLEX	0.0172414	1.7139969789518352
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	1.7139969789518352
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.7139969789518352
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.7139969789518352
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.7139969789518352
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.7139969789518352
DIASTEMATOMYELIA	0.0172414	1.7139969789518352
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.7139969789518352
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.7139969789518352
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.7139969789518352
JUMPING FRENCHMAN OF MAINE	0.0172414	1.7139969789518352
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	1.7139969789518352
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.7139969789518352
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.7139969789518352
CERVICAL RIB	0.0172414	1.7139969789518352
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.7139969789518352
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.7139969789518352
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.7139969789518352
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.7139969789518352
ALCOHOL DEPENDENCE	0.0172414	1.7139969789518352
269800 SENILE PLAQUE FORMATION	0.0172414	1.7139969789518352
MOTION SICKNESS	0.0172414	1.7139969789518352
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	1.7139969789518352
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.7139969789518352
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.7139969789518352
OCULOCEREBRORENAL SYNDROME OF LOWE	0.017218484	1.7117188603089373
CUTANEOUS MASTOCYTOSIS	0.017186899999999998	1.7085790410028938
TSH-SECRETING PITUITARY ADENOMA	0.017156169	1.7055240198816293
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.017156169	1.7055240198816293
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.01712627	1.7025517092993288
ACROOSTEOLYSIS DOMINANT TYPE	0.017104965	1.7004337429139673
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.017053125	1.6952802401016165
IMMUNOGLOBULIN A VASCULITIS	0.016967859000000002	1.6868038016217193
BERNARD-SOULIER SYNDROME	0.016967859000000002	1.6868038016217193
OSTEOGENESIS IMPERFECTA	0.016951795	1.6852068519848051
DYSKERATOSIS CONGENITA	0.016951795	1.6852068519848051
RHEUMATIC FEVER	0.01692145	1.6821902037818586
MELAS	0.01692145	1.6821902037818586
MONOSOMY 22Q13.3	0.016866068999999997	1.6766846841203844
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.016866068999999997	1.6766846841203844
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.016815965000000002	1.6717037600287563
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.01666782	1.6569764129196571
GITELMAN SYNDROME	0.01664008	1.654218732209499
POSTORGASMIC ILLNESS SYNDROME	0.01661475	1.6517006337095599
BABESIOSIS	0.01661475	1.6517006337095599
GIANT CELL ARTERITIS	0.01661475	1.6517006337095599
FAMILIAL COLD URTICARIA	0.01661475	1.6517006337095599
HODGKIN LYMPHOMA	0.01661475	1.6517006337095599
OSTEOGENESIS IMPERFECTA, TYPE V	0.01659779	1.6500146111845315
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.01659779	1.6500146111845315
MUCOPOLYSACCHARIDOSIS TYPE 2	0.016414419	1.6317853873380121
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.016414419	1.6317853873380121
FANCONI ANEMIA	0.016379625000000002	1.6283264564573616
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.016379625000000002	1.6283264564573616
CHROMOSOME 17Q12 DELETION SYNDROME	0.016379625000000002	1.6283264564573616
FG SYNDROME TYPE 1	0.016362359	1.6266100139504545
CITRULLINEMIA TYPE I	0.016360688999999998	1.6264439964022943
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.016255093999999998	1.615946617361589
RIFT VALLEY FEVER	0.016086378999999998	1.59917437147066
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.016060639	1.5966155141714726
THROMBOCYTOPENIA 1	0.016056479999999998	1.5962020608883594
MACS SYNDROME	0.015950875	1.5857036877305992
RIN2 SYNDROME	0.015950875	1.5857036877305992
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.015950875	1.5857036877305992
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.015926019	1.5832327103790602
VARIANT ABETA2M AMYLOIDOSIS	0.015872999999999998	1.577962001165942
RADICULONEUROPATHY, FATAL NEONATAL	0.015872999999999998	1.577962001165942
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.015872999999999998	1.577962001165942
PANCREATIC COLIPASE DEFICIENCY	0.015872999999999998	1.577962001165942
WILD TYPE ATTR AMYLOIDOSIS	0.015872999999999998	1.577962001165942
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.015872999999999998	1.577962001165942
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.015872999999999998	1.577962001165942
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.015872999999999998	1.577962001165942
ACRODERMATITIS ENTEROPATHICA	0.015872999999999998	1.577962001165942
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.015872999999999998	1.577962001165942
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.015872999999999998	1.577962001165942
CONGENITAL SHORT BOWEL SYNDROME	0.015872999999999998	1.577962001165942
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.015872999999999998	1.577962001165942
IMMUNODEFICIENCY 36; IMD36	0.015872999999999998	1.577962001165942
IMMUNODEFICIENCY 46; IMD46	0.015872999999999998	1.577962001165942
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.015872999999999998	1.577962001165942
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.015872999999999998	1.577962001165942
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.015872999999999998	1.577962001165942
AA AMYLOIDOSIS	0.015872999999999998	1.577962001165942
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01581916	1.5726096749426215
MARSILI SYNDROME; MARSIS	0.01568564	1.559336224026243
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.01568564	1.559336224026243
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.015643644999999998	1.5551614294543932
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.015643644999999998	1.5551614294543932
KEPPEN-LUBINSKY SYNDROME	0.015620944	1.5529046843281749
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.015610404	1.5518568849523613
POLYCYTHEMIA VERA	0.01554496	1.5453509852985905
CONGENITAL MEGACALYCOSIS	0.0153846	1.5294093242069902
JOUBERT SYNDROME 35; JBTS35	0.0153846	1.5294093242069902
EVEN-PLUS SYNDROME	0.0153846	1.5294093242069902
SECKEL SYNDROME 9; SCKL9	0.0153846	1.5294093242069902
BARE LYMPHOCYTE SYNDROME, TYPE II	0.0153846	1.5294093242069902
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.0153846	1.5294093242069902
PRIMARY HYPEROXALURIA TYPE 1	0.0153846	1.5294093242069902
PRIMARY HYPEROXALURIA TYPE 2	0.0153846	1.5294093242069902
BLADDER EXSTROPHY	0.0153846	1.5294093242069902
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.0153846	1.5294093242069902
POSTERIOR URETHRAL VALVE	0.0153846	1.5294093242069902
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0153846	1.5294093242069902
CONGENITAL PRIMARY MEGAURETER	0.0153846	1.5294093242069902
ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY	0.0153846	1.5294093242069902
POLYCYSTIC KIDNEY DISEASE 2	0.0153846	1.5294093242069902
HAND-FOOT-GENITAL SYNDROME	0.0153846	1.5294093242069902
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0153846	1.5294093242069902
REACTIVE ARTHRITIS	0.0153846	1.5294093242069902
CURRARINO SYNDROME	0.0153846	1.5294093242069902
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0153846	1.5294093242069902
SMALL CELL CARCINOMA OF THE BLADDER	0.0153846	1.5294093242069902
HARDIKAR SYNDROME	0.0153846	1.5294093242069902
GOOD SYNDROME	0.0153846	1.5294093242069902
109820 BLADDER DIVERTICULUM	0.0153846	1.5294093242069902
CORNELIA DE LANGE SYNDROME	0.015260069	1.5170294851112178
15Q OVERGROWTH SYNDROME	0.015246114	1.5156421947611725
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.015180260000000001	1.5090955363081529
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.01510989	1.5020999345931623
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.015079525	1.4990812981561052
ALSTROM SYNDROME; ALMS	0.015079525	1.4990812981561052
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.015068985	1.4980334987802915
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.01502588	1.4937483572153538
LOEYS-DIETZ SYNDROME 5	0.01495585	1.486786555480228
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.01495585	1.486786555480228
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.01495585	1.486786555480228
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.01488698	1.479940071323465
OSTEOPETROSIS AND RELATED DISORDERS	0.01488698	1.479940071323465
RIGID SPINE SYNDROME	0.014883925000000001	1.4796363685632081
MALT LYMPHOMA	0.01480984	1.4722714523623397
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.014625919	1.4539875520778036
WHIM SYNDROME	0.014625919	1.4539875520778036
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.014430319	1.4345426224849065
TIMOTHY SYNDROME; TS	0.014430319	1.4345426224849065
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.014422148999999999	1.4337304288510926
FABRY DISEASE	0.014396818999999998	1.4312123303511535
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.014348679999999999	1.4264267502608035
MEIER-GORLIN SYNDROME 2; MGORS2	0.014348679999999999	1.4264267502608035
LOCALIZED EPIDERMOLYSIS BULLOSA SIMPLEX	0.01431483	1.4230616640301308
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.0140845	1.400164165905734
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.0140845	1.400164165905734
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0140845	1.400164165905734
CYSTIC FIBROSIS	0.0140845	1.400164165905734
LIGNEOUS CONJUNCTIVITIS	0.0140845	1.400164165905734
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.0140845	1.400164165905734
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0140845	1.400164165905734
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0140845	1.400164165905734
BRAIN-LUNG-THYROID SYNDROME	0.0140845	1.400164165905734
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.0140845	1.400164165905734
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0140845	1.400164165905734
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.0140845	1.400164165905734
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.0140845	1.400164165905734
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.0140845	1.400164165905734
TRIMETHYLAMINURIA	0.0140845	1.400164165905734
TRACHEOPATHIA OSTEOPLASTICA	0.0140845	1.400164165905734
MASP2 DEFICIENCY	0.0140845	1.400164165905734
LEPTIN DEFICIENCY OR DYSFUNCTION	0.0140845	1.400164165905734
ROWLEY-ROSENBERG SYNDROME	0.0140845	1.400164165905734
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0140845	1.400164165905734
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.0140845	1.400164165905734
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0140845	1.400164165905734
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.0140845	1.400164165905734
SCHINZEL-GIEDION SYNDROME	0.0140845	1.400164165905734
CILIARY DYSKINESIA, PRIMARY, 33	0.0140845	1.400164165905734
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0140845	1.400164165905734
PULMONARY BLASTOMA	0.0140845	1.400164165905734
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.01407396	1.3991163665299204
GANGLIOCYTOMA	0.014063675000000001	1.3980939171390057
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.014014943999999998	1.393249485319008
BENIGN FAMILIAL INFANTILE EPILEPSY	0.013891439	1.3809716426330636
BEHÇET DISEASE	0.013891439	1.3809716426330636
MALIGNANT ATROPHIC PAPULOSIS	0.013891439	1.3809716426330636
VIRAL HEMORRHAGIC FEVER	0.013891439	1.3809716426330636
SYSTEMIC SCLEROSIS	0.013891439	1.3809716426330636
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.013888900000000001	1.3807192363128369
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.013888900000000001	1.3807192363128369
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.013888900000000001	1.3807192363128369
IMMUNODEFICIENCY 32B; IMD32B	0.013888900000000001	1.3807192363128369
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.013888900000000001	1.3807192363128369
MOUNIER-KÜHN SYNDROME	0.013888900000000001	1.3807192363128369
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.013888900000000001	1.3807192363128369
SLC35A1-CDG	0.013888900000000001	1.3807192363128369
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.013888900000000001	1.3807192363128369
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.013888900000000001	1.3807192363128369
BRONCHIAL NEUROENDOCRINE TUMOR	0.013888900000000001	1.3807192363128369
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.013888900000000001	1.3807192363128369
215030 CHOLESTEROL PNEUMONIA	0.013888900000000001	1.3807192363128369
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.013888900000000001	1.3807192363128369
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.013888900000000001	1.3807192363128369
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.013888900000000001	1.3807192363128369
ROIFMAN-CHITAYAT SYNDROME	0.013888900000000001	1.3807192363128369
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.013888900000000001	1.3807192363128369
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.013888900000000001	1.3807192363128369
IMMUNODEFICIENCY 13; IMD13	0.013888900000000001	1.3807192363128369
MUSCULAR HYPERTONIA, LETHAL	0.013888900000000001	1.3807192363128369
MELIOIDOSIS	0.013888900000000001	1.3807192363128369
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.013888900000000001	1.3807192363128369
GRAFT VERSUS HOST DISEASE	0.013888900000000001	1.3807192363128369
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.013888900000000001	1.3807192363128369
COMMON VARIABLE IMMUNODEFICIENCY	0.013888900000000001	1.3807192363128369
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.013888900000000001	1.3807192363128369
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.013888900000000001	1.3807192363128369
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.013880729999999999	1.3799070426790228
LAMBERT-EATON MYASTHENIC SYNDROME	0.013880729999999999	1.3799070426790228
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.013773464999999999	1.3692436460901571
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.013658115	1.357776505862444
SYSTEMIC MASTOCYTOSIS	0.0136408	1.3560551921819686
FAMILIAL THROMBOCYTOSIS	0.013610068999999999	1.353000171060704
SCRUB TYPHUS	0.013610068999999999	1.353000171060704
SCHAAF-YANG SYNDROME; SHFYNG	0.013592364	1.3512400868150891
PITT-HOPKINS SYNDROME	0.013592364	1.3512400868150891
EMANUEL SYNDROME	0.013592364	1.3512400868150891
DISTAL MONOSOMY 10Q	0.013583119	1.350321025597879
PROPIONIC ACIDEMIA	0.013546809	1.3467113865717129
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.013441204	1.3362130134139525
LOWE OCULOCEREBRORENAL SYNDROME	0.013441204	1.3362130134139525
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.01343294	1.3353914750798233
PFAPA SYNDROME	0.01335002	1.3271482564609938
KAWASAKI DISEASE	0.01335002	1.3271482564609938
WALDENSTRÖM MACROGLOBULINEMIA	0.01335002	1.3271482564609938
BLACKFAN-DIAMOND ANEMIA	0.01335002	1.3271482564609938
LEGIONELLOSIS	0.01335002	1.3271482564609938
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.013179179	1.3101646612842035
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.013174505	1.309700010972766
PERIVENTRICULAR NODULAR HETEROTOPIA	0.013174505	1.309700010972766
OKAMOTO SYNDROME	0.013174505	1.309700010972766
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.013139604	1.3062304430396283
EPISODIC ATAXIA TYPE 1	0.013068650000000001	1.2991767848886344
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.012968145	1.2891854114288483
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.012928134	1.2852078496806818
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.012814479	1.2739092122937656
ALEXANDER DISEASE	0.012800184	1.2724881219638553
MARSHALL SYNDROME	0.012778439999999999	1.270326513839786
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.01266309	1.258859373612073
GM1 GANGLIOSIDOSIS	0.012647544	1.2573139192386007
HERMANSKY-PUDLAK SYNDROME	0.01263776	1.256341275112134
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.012540279	1.2466505226497349
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.012516209	1.2442576828987073
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.012516209	1.2442576828987073
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.012516209	1.2442576828987073
KAGAMI-OGATA SYNDROME	0.012516209	1.2442576828987073
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.01249387	1.2420369248098742
TYPHOID	0.01249387	1.2420369248098742
PARATHYROID CARCINOMA	0.01249387	1.2420369248098742
PRIMARY PARATHYROID HYPERPLASIA	0.01249387	1.2420369248098742
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.012478499999999998	1.240508966896567
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.012446179	1.2372958811635815
MENKES DISEASE	0.012351978999999999	1.2279312985068793
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.012338914	1.2266324845747156
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.012338914	1.2266324845747156
JABERI-ELAHI SYNDROME; JABELS	0.012338914	1.2266324845747156
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.01227306	1.2200858261216962
CLASSIC HOMOCYSTINURIA	0.012270043999999999	1.2197860004179526
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.01224951	1.2177446804575205
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012144578999999999	1.207313310789257
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.012106125	1.2034905330665309
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.012106125	1.2034905330665309
WHITE-SUTTON SYNDROME; WHSUS	0.01205592	1.1984995683926483
ZTTK SYNDROME; ZTTKS	0.012038974	1.1968149376314967
SEVERE HEMOPHILIA A	0.01199886	1.1928271364776653
DENGUE FEVER	0.01199886	1.1928271364776653
CONGENITAL ANALBUMINEMIA	0.01194946	1.1879161982266981
EBSTEIN MALFORMATION	0.01194946	1.1879161982266981
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.01190476	1.1834724949915116
TRICHOTHIODYSTROPHY	0.0119031	1.1833074715604064
CARDIOFACIOCUTANEOUS SYNDROME	0.011867525	1.1797709001377716
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.011845743999999998	1.1776056137805992
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.011845743999999998	1.1776056137805992
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.01183589	1.1766260108347486
GAUCHER DISEASE	0.01181056	1.1741079123348095
MASTOCYTOSIS	0.01181056	1.1741079123348095
ACUTE INTERMITTENT PORPHYRIA	0.011805158999999999	1.173570989713484
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.011797495	1.172809098402646
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.011797495	1.172809098402646
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.011779829	1.1710528912135452
SPONTANEOUS PERIODIC HYPOTHERMIA	0.011779829	1.1710528912135452
INSULINOMA	0.011779829	1.1710528912135452
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.011779829	1.1710528912135452
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.011652519	1.1583967869882295
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.011652519	1.1583967869882295
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.011652519	1.1583967869882295
CAMOS SYNDROME	0.011652519	1.1583967869882295
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.011633059	1.1564622351994882
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.01160316	1.1534899246171875
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.011497555	1.142991551459427
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.011497555	1.142991551459427
SMITH-MAGENIS SYNDROME	0.011423164	1.1355962152766805
CHROMOSOME 1P36 DELETION SYNDROME	0.011423164	1.1355962152766805
49,XXXXY SYNDROME	0.011423164	1.1355962152766805
ALPORT SYNDROME	0.01139158	1.1324563959706373
COHEN SYNDROME	0.011343889	1.1277153523243444
MONOSOMY 18Q	0.011343889	1.1277153523243444
MALAN OVERGROWTH SYNDROME	0.011340364	1.1273649260625094
SAETHRE-CHOTZEN SYNDROME	0.011340364	1.1273649260625094
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.011304324999999999	1.1237822276085294
THYROTOXIC PERIODIC PARALYSIS	0.01126374	1.1197476035414144
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.01126374	1.1197476035414144
ERDHEIM-CHESTER DISEASE	0.01123841	1.1172295050414753
THYMIC CARCINOMA	0.01123841	1.1172295050414753
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.01123841	1.1172295050414753
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.01123841	1.1172295050414753
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.011123224	1.1057786683334616
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.011123224	1.1057786683334616
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011123224	1.1057786683334616
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011113979	1.1048596071162513
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	1.1045734008161598
PATELLA APLASIA-HYPOPLASIA	0.0111111	1.1045734008161598
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	1.1045734008161598
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	1.1045734008161598
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	1.1045734008161598
ACROMIAL DIMPLES	0.0111111	1.1045734008161598
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	1.1045734008161598
PSEUDOATROPHODERMA COLLI	0.0111111	1.1045734008161598
PIGMENTED PURPURIC ERUPTION	0.0111111	1.1045734008161598
PILONIDAL SINUS	0.0111111	1.1045734008161598
SAY SYNDROME	0.0111111	1.1045734008161598
DERMAL RIDGES, PATTERNLESS	0.0111111	1.1045734008161598
DERMATOSIS PAPULOSA NIGRA	0.0111111	1.1045734008161598
TRICHILEMMAL CYST 1	0.0111111	1.1045734008161598
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	1.1045734008161598
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	1.1045734008161598
131600 EPIDERMOID CYSTS	0.0111111	1.1045734008161598
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	1.1045734008161598
TRIOPIA	0.0111111	1.1045734008161598
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	1.1045734008161598
SYRINGOMAS, MULTIPLE	0.0111111	1.1045734008161598
CIRCUMVALLATE PLACENTA SYNDROME	0.0111111	1.1045734008161598
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	1.1045734008161598
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0111111	1.1045734008161598
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	1.1045734008161598
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	1.1045734008161598
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	1.1045734008161598
LICHEN PLANUS, FAMILIAL	0.0111111	1.1045734008161598
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	1.1045734008161598
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	1.1045734008161598
LENTIGINES	0.0111111	1.1045734008161598
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	1.1045734008161598
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	1.1045734008161598
CAROTENEMIA, FAMILIAL	0.0111111	1.1045734008161598
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	1.1045734008161598
KYRLE DISEASE	0.0111111	1.1045734008161598
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	1.1045734008161598
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0111111	1.1045734008161598
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	1.1045734008161598
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	1.1045734008161598
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	1.1045734008161598
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	1.1045734008161598
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	1.1045734008161598
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	1.1045734008161598
PARANA HARD-SKIN SYNDROME	0.0111111	1.1045734008161598
FUTCHER LINE	0.0111111	1.1045734008161598
PRENATAL BOWING	0.0111111	1.1045734008161598
GLOMUVENOUS MALFORMATIONS	0.0111111	1.1045734008161598
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	1.1045734008161598
CURRY-JONES SYNDROME	0.0111111	1.1045734008161598
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	1.1045734008161598
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	1.1045734008161598
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	1.1045734008161598
KERATOSIS, FAMILIAL ACTINIC	0.0111111	1.1045734008161598
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0111111	1.1045734008161598
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	1.1045734008161598
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	1.1045734008161598
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	1.1045734008161598
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	1.1045734008161598
DUPLICATION/INVERSION 15Q11	0.011043948999999999	1.0978978053811257
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.011043948999999999	1.0978978053811257
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.011043948999999999	1.0978978053811257
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.011043948999999999	1.0978978053811257
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.010970404	1.0905865715012195
COFFIN-SIRIS SYNDROME 8; CSS8	0.010970404	1.0905865715012195
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.010970404	1.0905865715012195
POLYMYOSITIS	0.01096368	1.0899181271935374
ARTERIAL TORTUOSITY SYNDROME	0.010856415	1.0792547306046718
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.010850718999999998	1.078688481530228
DERMOTRICHIC SYNDROME	0.010850718999999998	1.078688481530228
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.010850718999999998	1.078688481530228
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.010850718999999998	1.078688481530228
ZLOTOGORA-OGUR SYNDROME	0.010850718999999998	1.078688481530228
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.010850718999999998	1.078688481530228
MARFAN SYNDROME; MFS	0.01080247	1.0738919661522748
STICKLER SYNDROME, TYPE II	0.01080247	1.0738919661522748
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.01080247	1.0738919661522748
MYOPATHIC EHLERS-DANLOS SYNDROME	0.01080247	1.0738919661522748
1P21.3 MICRODELETION SYNDROME	0.01080247	1.0738919661522748
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.010758934000000001	1.069563978142273
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0107336	1.0670454819955117
HALLERMANN-STREIFF SYNDROME	0.0107336	1.0670454819955117
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.010581805	1.051955282161392
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.01057256	1.0510362209441817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.01057256	1.0510362209441817
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.01057256	1.0510362209441817
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.01057256	1.0510362209441817
TYSHCHENKO SYNDROME	0.01057256	1.0510362209441817
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.01057256	1.0510362209441817
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.01050253	1.0440744192090559
NEONATAL MARFAN SYNDROME	0.01050253	1.0440744192090559
X-LINKED EHLERS-DANLOS SYNDROME	0.01046867	1.0407083388613283
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.010428985	1.03676318532915
IMMUNODEFICIENCY 23; IMD23	0.010428985	1.03676318532915
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.010428985	1.03676318532915
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.010428985	1.03676318532915
SHWACHMAN-DIAMOND SYNDROME	0.010428985	1.03676318532915
PITT-HOPKINS SYNDROME	0.010428139	1.0366790830263093
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.010345339	1.0284477938121381
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.010345339	1.0284477938121381
CYCLIC VOMITING SYNDROME	0.010345339	1.0284477938121381
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.010345339	1.0284477938121381
PHACE ASSOCIATION	0.010345339	1.0284477938121381
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.010345339	1.0284477938121381
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.010345339	1.0284477938121381
HARTNUP DISEASE	0.010345339	1.0284477938121381
EPISODIC ATAXIA TYPE 6	0.010345339	1.0284477938121381
PULMONARY ARTERIOVENOUS MALFORMATION	0.010345339	1.0284477938121381
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.010345339	1.0284477938121381
DISTAL 16P11.2 MICRODELETION SYNDROME	0.010345339	1.0284477938121381
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.010345339	1.0284477938121381
EPISODIC ATAXIA, TYPE 6	0.010345339	1.0284477938121381
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.010345339	1.0284477938121381
SNEDDON SYNDROME	0.010345339	1.0284477938121381
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.010345339	1.0284477938121381
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.010345339	1.0284477938121381
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.010345339	1.0284477938121381
ATYPICAL TERATOID RHABDOID TUMOR	0.010345339	1.0284477938121381
RABIES	0.010345339	1.0284477938121381
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.010345339	1.0284477938121381
BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS	0.010309299999999999	1.0248650953581584
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.010309299999999999	1.0248650953581584
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.010309299999999999	1.0248650953581584
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.010309299999999999	1.0248650953581584
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.010309299999999999	1.0248650953581584
BATHING SUIT ICHTHYOSIS	0.010309299999999999	1.0248650953581584
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.010309299999999999	1.0248650953581584
HELIX SYNDROME; HELIX	0.010309299999999999	1.0248650953581584
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.010309299999999999	1.0248650953581584
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.010309299999999999	1.0248650953581584
AMELO-ONYCHO-HYPOHIDROTIC SYNDROME	0.010309299999999999	1.0248650953581584
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	0.010309299999999999	1.0248650953581584
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.010309299999999999	1.0248650953581584
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.010309299999999999	1.0248650953581584
CHAND SYNDROME	0.010309299999999999	1.0248650953581584
DERMOODONTODYSPLASIA	0.010309299999999999	1.0248650953581584
ABSENCE OF FINGERPRINTS-CONGENITAL MILIA SYNDROME	0.010309299999999999	1.0248650953581584
LELIS SYNDROME	0.010309299999999999	1.0248650953581584
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.010309299999999999	1.0248650953581584
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.010309299999999999	1.0248650953581584
DAHLBERG-BORER-NEWCOMER SYNDROME	0.010309299999999999	1.0248650953581584
EEC SYNDROME	0.010309299999999999	1.0248650953581584
JOHNSON NEUROECTODERMAL SYNDROME	0.010309299999999999	1.0248650953581584
SPINOCEREBELLAR ATAXIA TYPE 34	0.010309299999999999	1.0248650953581584
RECESSIVE X-LINKED ICHTHYOSIS	0.010309299999999999	1.0248650953581584
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.010309299999999999	1.0248650953581584
KID SYNDROME	0.010309299999999999	1.0248650953581584
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6	0.010309299999999999	1.0248650953581584
LARON SYNDROME	0.010309299999999999	1.0248650953581584
FRONTONASAL DYSPLASIA 2; FND2	0.010309299999999999	1.0248650953581584
DIGITAL EXTENSOR MUSCLE APLASIA-POLYNEUROPATHY	0.010309299999999999	1.0248650953581584
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.010309299999999999	1.0248650953581584
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.010309299999999999	1.0248650953581584
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.010309299999999999	1.0248650953581584
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.010309299999999999	1.0248650953581584
ROSSELLI-GULIENETTI SYNDROME	0.010309299999999999	1.0248650953581584
TETRASOMY 12P	0.010309299999999999	1.0248650953581584
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.010309299999999999	1.0248650953581584
CYSTINOSIS, NEPHROPATHIC; CTNS	0.010309299999999999	1.0248650953581584
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.010309299999999999	1.0248650953581584
ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE; ECTD12	0.010309299999999999	1.0248650953581584
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.010309299999999999	1.0248650953581584
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.010309299999999999	1.0248650953581584
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.01016862	1.0108798566305062
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.01016862	1.0108798566305062
EVANS SYNDROME	0.01016862	1.0108798566305062
ACUTE PROMYELOCYTIC LEUKEMIA	0.01016862	1.0108798566305062
ACTH-INDEPENDENT CUSHING SYNDROME	0.01016862	1.0108798566305062
ACTH-DEPENDENT CUSHING SYNDROME	0.01016862	1.0108798566305062
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.01016862	1.0108798566305062
AREGENERATIVE ANEMIA	0.01016862	1.0108798566305062
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.01016862	1.0108798566305062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.010128199	1.0068615360830904
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.010128199	1.0068615360830904
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.010086685	1.0027345585415797
PSEUDOXANTHOMA ELASTICUM	0.010086685	1.0027345585415797
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.010020933999999999	0.9961981394942248
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.009975379	0.9916694392508484
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.009975379	0.9916694392508484
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009975379	0.9916694392508484
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.009975379	0.9916694392508484
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.009975379	0.9916694392508484
2Q37 MICRODELETION SYNDROME	0.009975379	0.9916694392508484
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.009975379	0.9916694392508484
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.009975379	0.9916694392508484
ECTODERMAL DYSPLASIA SYNDROME	0.009975379	0.9916694392508484
NETHERTON SYNDROME	0.009975379	0.9916694392508484
CLASSIC PHENYLKETONURIA	0.009975379	0.9916694392508484
CHROMOSOME 2Q37 DELETION SYNDROME	0.009975379	0.9916694392508484
PHENYLKETONURIA	0.009975379	0.9916694392508484
SULFOCYSTEINURIA	0.009975379	0.9916694392508484
MICROFORM HOLOPROSENCEPHALY	0.009939804	0.9881328678282139
PELIZAEUS-MERZBACHER DISEASE	0.009939804	0.9881328678282139
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.00988672	0.9828556968542396
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00988672	0.9828556968542396
GAPO SYNDROME; GAPOS	0.009869774	0.9811710660930881
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.009869774	0.9811710660930881
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.009869774	0.9811710660930881
EPISODIC ATAXIA, TYPE 2	0.00980392	0.9746244076400685
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00980392	0.9746244076400685
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.00980392	0.9746244076400685
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00980392	0.9746244076400685
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.9746244076400685
ABETAL34V AMYLOIDOSIS	0.00980392	0.9746244076400685
PAROXYSMAL KINESIGENIC DYSKINESIA	0.00980392	0.9746244076400685
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.9746244076400685
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.9746244076400685
STORMORKEN SYNDROME; STRMK	0.00980392	0.9746244076400685
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00980392	0.9746244076400685
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.9746244076400685
ROLANDIC EPILEPSY	0.00980392	0.9746244076400685
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.9746244076400685
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.9746244076400685
FAMILIAL CERVICAL ARTERY DISSECTION	0.00980392	0.9746244076400685
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00980392	0.9746244076400685
EPISODIC ATAXIA TYPE 7	0.00980392	0.9746244076400685
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.9746244076400685
KERION CELSI	0.00980392	0.9746244076400685
FAMILIAL PAROXYSMAL ATAXIA	0.00980392	0.9746244076400685
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00980392	0.9746244076400685
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00980392	0.9746244076400685
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.9746244076400685
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00980392	0.9746244076400685
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.00980392	0.9746244076400685
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.9746244076400685
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.009800904	0.974324581936325
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.009746214	0.9688877557633417
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00958678	0.9530381499110208
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00958678	0.9530381499110208
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00958678	0.9530381499110208
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00958678	0.9530381499110208
INFANTILE DYSTONIA-PARKINSONISM	0.00958678	0.9530381499110208
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.009489189	0.9433364621610186
GLIOBLASTOMA	0.009463859	0.9408183636610794
ACQUIRED METHEMOGLOBINEMIA	0.009463859	0.9408183636610794
NON-FUNCTIONING PITUITARY ADENOMA	0.009463859	0.9408183636610794
LUJO HEMORRHAGIC FEVER	0.009463859	0.9408183636610794
NIPAH VIRUS DISEASE	0.009463859	0.9408183636610794
GRANULOMATOSIS WITH POLYANGIITIS	0.009463859	0.9408183636610794
EBOLA HEMORRHAGIC FEVER	0.009463859	0.9408183636610794
LASSA FEVER	0.009463859	0.9408183636610794
PROLACTINOMA	0.009463859	0.9408183636610794
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00943396	0.9378460530787787
ACRAL PEELING SKIN SYNDROME	0.00943396	0.9378460530787787
ELASTODERMA	0.00943396	0.9378460530787787
NEUTROPHIL CHEMOTACTIC RESPONSE	0.00943396	0.9378460530787787
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.00943396	0.9378460530787787
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.00943396	0.9378460530787787
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00943396	0.9378460530787787
PELGER-HUET ANOMALY; PHA	0.00943396	0.9378460530787787
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00943396	0.9378460530787787
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00943396	0.9378460530787787
CHRONIC GRANULOMATOUS DISEASE	0.00943396	0.9378460530787787
BLAU SYNDROME	0.00943396	0.9378460530787787
CLASSIC MYCOSIS FUNGOIDES	0.00943396	0.9378460530787787
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00943396	0.9378460530787787
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00943396	0.9378460530787787
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00943396	0.9378460530787787
IMMUNODEFICIENCY 55; IMD55	0.00943396	0.9378460530787787
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00943396	0.9378460530787787
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00943396	0.9378460530787787
PROTOPORPHYRIA, ERYTHROPOIETIC	0.00943396	0.9378460530787787
CRANIO-OSTEOARTHROPATHY	0.00943396	0.9378460530787787
PITYRIASIS RUBRA PILARIS	0.00943396	0.9378460530787787
IGE RESPONSIVENESS, ATOPIC	0.00943396	0.9378460530787787
DISTAL TRISOMY 5Q	0.00943396	0.9378460530787787
DERMATITIS, ATOPIC	0.00943396	0.9378460530787787
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00943396	0.9378460530787787
PORPHYRIA CUTANEA TARDA, TYPE I	0.00943396	0.9378460530787787
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00943396	0.9378460530787787
XQ12-Q13.3 DUPLICATION SYNDROME	0.00943396	0.9378460530787787
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00943396	0.9378460530787787
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.00943396	0.9378460530787787
SAY-BARBER-MILLER SYNDROME	0.00943396	0.9378460530787787
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00943396	0.9378460530787787
8Q21.11 MICRODELETION SYNDROME	0.00943396	0.9378460530787787
TEMPLE SYNDROME	0.009398385	0.9343094816561441
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.009398385	0.9343094816561441
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009398385	0.9343094816561441
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.009398385	0.9343094816561441
CARTILAGE-HAIR HYPOPLASIA; CHH	0.009328355	0.9273476799210183
ODONTOCHONDRODYSPLASIA; ODCD	0.009328355	0.9273476799210183
15Q26 OVERGROWTH SYNDROME	0.009328355	0.9273476799210183
GIANT AXONAL NEUROPATHY	0.009328355	0.9273476799210183
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.009328355	0.9273476799210183
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.009328355	0.9273476799210183
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.00928673	0.9232096676801986
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00928673	0.9232096676801986
ATHYREOSIS	0.00928673	0.9232096676801986
PERIPHERAL HYPOTHYROIDISM	0.00928673	0.9232096676801986
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00928673	0.9232096676801986
GNATHODIAPHYSEAL DYSPLASIA	0.009259485	0.9205011957642553
COLE-CARPENTER SYNDROME	0.009259485	0.9205011957642553
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.009259485	0.9205011957642553
MAFFUCCI SYNDROME	0.009259485	0.9205011957642553
OSTEOGENESIS IMPERFECTA, TYPE IV	0.009259485	0.9205011957642553
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.009259485	0.9205011957642553
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.009259485	0.9205011957642553
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.009259485	0.9205011957642553
BRUCK SYNDROME	0.009259485	0.9205011957642553
CLEIDOCRANIAL DYSPLASIA	0.009259485	0.9205011957642553
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.009259485	0.9205011957642553
OSTEOGENESIS IMPERFECTA, TYPE IX	0.009259485	0.9205011957642553
COLE-CARPENTER SYNDROME 1; CLCRP1	0.009259485	0.9205011957642553
GERODERMA OSTEODYSPLASTICA	0.009259485	0.9205011957642553
MULTIPLE OSTEOCHONDROMAS	0.009259485	0.9205011957642553
CAMPOMELIC DYSPLASIA	0.009259485	0.9205011957642553
MONOSOMY 5P	0.009259485	0.9205011957642553
INCONTINENTIA PIGMENTI	0.009228754	0.9174461746429909
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.009228754	0.9174461746429909
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00909166	0.9038174262912084
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00909166	0.9038174262912084
EHLERS-DANLOS SYNDROME, TYPE I	0.00909166	0.9038174262912084
BOHRING-OPITZ SYNDROME	0.009025908999999999	0.8972810072438535
BOHRING-OPITZ SYNDROME	0.009025908999999999	0.8972810072438535
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.009025908999999999	0.8972810072438535
RETT SYNDROME, CONGENITAL VARIANT	0.008954024	0.8901347967950529
22Q11.2 DELETION SYNDROME	0.008954024	0.8901347967950529
48,XXXY SYNDROME	0.008954024	0.8901347967950529
1P36 DELETION SYNDROME	0.008954024	0.8901347967950529
48,XXYY SYNDROME	0.008954024	0.8901347967950529
HOLOPROSENCEPHALY	0.008954024	0.8901347967950529
RETT SYNDROME; RTT	0.008954024	0.8901347967950529
KLEEFSTRA SYNDROME	0.008954024	0.8901347967950529
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00894777	0.8895130759889489
TURCOT SYNDROME WITH POLYPOSIS	0.00894777	0.8895130759889489
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008944779	0.8892157355778427
ADAMS-OLIVER SYNDROME	0.008944779	0.8892157355778427
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.8892157355778427
KAGAMI-OGATA SYNDROME	0.008944779	0.8892157355778427
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008944779	0.8892157355778427
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.8892157355778427
INFANTILE SIALIC ACID STORAGE DISEASE	0.008944779	0.8892157355778427
ZELLWEGER SYNDROME	0.008944779	0.8892157355778427
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008944779	0.8892157355778427
CONGENITAL TOXOPLASMOSIS	0.008944779	0.8892157355778427
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008944779	0.8892157355778427
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.008944779	0.8892157355778427
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00892244	0.8869949774890097
RELAPSING FEVER	0.00892244	0.8869949774890097
PLAGUE	0.00892244	0.8869949774890097
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00892244	0.8869949774890097
PITUICYTOMA	0.00892244	0.8869949774890097
COLD AGGLUTININ DISEASE	0.00892244	0.8869949774890097
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00892244	0.8869949774890097
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00892244	0.8869949774890097
CARNEY TRIAD	0.00892244	0.8869949774890097
HELLP SYNDROME	0.00892244	0.8869949774890097
MARBURG HEMORRHAGIC FEVER	0.00892244	0.8869949774890097
PRIMARY FAMILIAL POLYCYTHEMIA	0.00892244	0.8869949774890097
FUNCTIONING GONADOTROPIC ADENOMA	0.00892244	0.8869949774890097
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00892244	0.8869949774890097
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.00892244	0.8869949774890097
HUGHES-STOVIN SYNDROME	0.00892244	0.8869949774890097
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00892244	0.8869949774890097
PONTIAC FEVER	0.00892244	0.8869949774890097
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00892244	0.8869949774890097
LYME DISEASE	0.00892244	0.8869949774890097
7Q11.23 MICRODUPLICATION SYNDROME	0.008874749	0.8822539338427169
MENTAL RETARDATION, X-LINKED 21	0.008874749	0.8822539338427169
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.008874749	0.8822539338427169
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.008874749	0.8822539338427169
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008874749	0.8822539338427169
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.008874749	0.8822539338427169
SIALURIA	0.008874749	0.8822539338427169
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.008874749	0.8822539338427169
CK SYNDROME	0.008874749	0.8822539338427169
MAN1B1-CDG	0.008874749	0.8822539338427169
ZIMMERMANN-LABAND SYNDROME	0.008874749	0.8822539338427169
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.008874749	0.8822539338427169
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.008805878999999999	0.8754074496859539
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.008805878999999999	0.8754074496859539
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.008805878999999999	0.8754074496859539
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.008805878999999999	0.8754074496859539
HYPOPHOSPHATASIA	0.008805878999999999	0.8754074496859539
KALLMANN SYNDROME	0.008805878999999999	0.8754074496859539
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.008805878999999999	0.8754074496859539
WOLCOTT-RALLISON SYNDROME	0.008805878999999999	0.8754074496859539
PRADER-WILLI-LIKE SYNDROME	0.008751189	0.8699706235129705
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.008751189	0.8699706235129705
DESANTO-SHINAWI SYNDROME	0.008751189	0.8699706235129705
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.008687335000000001	0.8636227884709212
PACHYDERMOPERIOSTOSIS	0.008687335000000001	0.8636227884709212
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.008687335000000001	0.8636227884709212
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.008687335000000001	0.8636227884709212
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.008687335000000001	0.8636227884709212
AICARDI SYNDROME	0.008412605	0.8363114106229832
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.008412605	0.8363114106229832
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.835392349405773
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.835392349405773
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.835392349405773
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.835392349405773
PEMPHIGOID GESTATIONIS	0.00840336	0.835392349405773
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.835392349405773
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.835392349405773
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.835392349405773
VACTERL/VATER ASSOCIATION	0.00840336	0.835392349405773
ROBERTS SYNDROME	0.00840336	0.835392349405773
RETINOPATHY OF PREMATURITY	0.00840336	0.835392349405773
DISTAL MONOSOMY 17Q	0.00840336	0.835392349405773
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.835392349405773
OMPHALOCELE	0.00840336	0.835392349405773
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.835392349405773
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.835392349405773
RENAL TUBULAR DYSGENESIS	0.00840336	0.835392349405773
YUNIS-VARON SYNDROME	0.00840336	0.835392349405773
COSTELLO SYNDROME; CSTLO	0.00840336	0.835392349405773
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.835392349405773
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.835392349405773
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.835392349405773
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.835392349405773
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.835392349405773
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.835392349405773
SCHISIS ASSOCIATION	0.00840336	0.835392349405773
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.835392349405773
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.835392349405773
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.835392349405773
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.835392349405773
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.835392349405773
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.835392349405773
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.835392349405773
NEMALINE MYOPATHY 10	0.00840336	0.835392349405773
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.835392349405773
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.835392349405773
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.835392349405773
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.835392349405773
FATCO SYNDROME	0.00840336	0.835392349405773
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.835392349405773
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.835392349405773
GMS SYNDROME	0.00840336	0.835392349405773
HEC SYNDROME	0.00840336	0.835392349405773
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.835392349405773
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.835392349405773
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.835392349405773
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.835392349405773
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.835392349405773
HYDROLETHALUS	0.00840336	0.835392349405773
BECKWITH-WIEDEMANN SYNDROME	0.00840336	0.835392349405773
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.835392349405773
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.835392349405773
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.835392349405773
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.835392349405773
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00840336	0.835392349405773
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.835392349405773
CRANIOSYNOSTOSIS 2	0.008386899	0.8337559333217818
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00833333	0.8284305476706472
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.00833333	0.8284305476706472
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00833333	0.8284305476706472
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00833333	0.8284305476706472
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.00833333	0.8284305476706472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00833333	0.8284305476706472
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00833333	0.8284305476706472
3MC SYNDROME 2	0.00833333	0.8284305476706472
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00833333	0.8284305476706472
EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	0.00833333	0.8284305476706472
MEESTER-LOEYS SYNDROME; MRLS	0.00833333	0.8284305476706472
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00833333	0.8284305476706472
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00833333	0.8284305476706472
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00833333	0.8284305476706472
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00833333	0.8284305476706472
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.00833333	0.8284305476706472
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00833333	0.8284305476706472
WARBURG MICRO SYNDROME 1	0.00833333	0.8284305476706472
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00833333	0.8284305476706472
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00833333	0.8284305476706472
WILSON DISEASE	0.00833333	0.8284305476706472
OCULO-PALATO-CEREBRAL SYNDROME	0.00833333	0.8284305476706472
NEMALINE MYOPATHY 7; NEM7	0.00833333	0.8284305476706472
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00826446	0.8215840635138841
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00826446	0.8215840635138841
ANTLEY-BIXLER SYNDROME	0.00826446	0.8215840635138841
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00826446	0.8215840635138841
OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES	0.00826446	0.8215840635138841
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00826446	0.8215840635138841
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00826446	0.8215840635138841
HYPOPHOSPHATASIA, ADULT	0.00826446	0.8215840635138841
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00826446	0.8215840635138841
JUVENILE PAGET DISEASE	0.00826446	0.8215840635138841
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00826446	0.8215840635138841
FAMILIAL PAPILLARY THYROID CARCINOMA WITH RENAL PAPILLARY NEOPLASIA	0.00826446	0.8215840635138841
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00826446	0.8215840635138841
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00826446	0.8215840635138841
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.00826446	0.8215840635138841
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.00826446	0.8215840635138841
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.00826446	0.8215840635138841
DENT DISEASE	0.00826446	0.8215840635138841
X-LINKED HYPOPHOSPHATEMIA	0.00826446	0.8215840635138841
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00826446	0.8215840635138841
DYSOSTEOSCLEROSIS	0.00826446	0.8215840635138841
GERODERMA OSTEODYSPLASTICUM; GO	0.00826446	0.8215840635138841
PAGET DISEASE OF BONE 6	0.00826446	0.8215840635138841
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00826446	0.8215840635138841
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00826446	0.8215840635138841
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00826446	0.8215840635138841
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00826446	0.8215840635138841
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00826446	0.8215840635138841
FAMILIAL PAPILLARY OR FOLLICULAR THYROID CARCINOMA	0.00826446	0.8215840635138841
ACHONDROGENESIS TYPE 1A	0.00826446	0.8215840635138841
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.00826446	0.8215840635138841
BUSCHKE-OLLENDORFF SYNDROME	0.00826446	0.8215840635138841
URBAN-ROGERS-MEYER SYNDROME	0.00826446	0.8215840635138841
MAZABRAUD SYNDROME	0.00826446	0.8215840635138841
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00826446	0.8215840635138841
INTERMEDIATE OSTEOPETROSIS	0.00826446	0.8215840635138841
MCCUNE-ALBRIGHT SYNDROME	0.00826446	0.8215840635138841
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00826446	0.8215840635138841
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00826446	0.8215840635138841
DENT DISEASE 1	0.00826446	0.8215840635138841
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00826446	0.8215840635138841
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00826446	0.8215840635138841
FAMILIAL PARATHYROID ADENOMA	0.00826446	0.8215840635138841
GRANGE SYNDROME; GRNG	0.00826446	0.8215840635138841
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00826446	0.8215840635138841
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.00826446	0.8215840635138841
PRIMARY HYPEROXALURIA	0.00826446	0.8215840635138841
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.008233729	0.8185290423926197
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.008233729	0.8185290423926197
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.008233729	0.8185290423926197
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.008233729	0.8185290423926197
FUCOSIDOSIS	0.008233729	0.8185290423926197
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.008233729	0.8185290423926197
TYROSINEMIA TYPE 2	0.008233729	0.8185290423926197
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.008233729	0.8185290423926197
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.008112555	0.8064829283921611
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.007958999	0.7912176645446818
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.007958999	0.7912176645446818
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.007958999	0.7912176645446818
XQ28 (MECP2) DUPLICATION	0.007958999	0.7912176645446818
DDOST-CDG	0.007958999	0.7912176645446818
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.007958999	0.7912176645446818
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.007958999	0.7912176645446818
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007958999	0.7912176645446818
MIXED CONNECTIVE TISSUE DISEASE	0.007933669	0.7886995660447429
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.007851733999999999	0.7805542679558161
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.007851733999999999	0.7805542679558161
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00769231	0.76470565622055
DIENCEPHALIC SYNDROME	0.00769231	0.76470565622055
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.00769231	0.76470565622055
PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE	0.00769231	0.76470565622055
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00769231	0.76470565622055
KERATOLYTIC WINTER ERYTHEMA	0.00769231	0.76470565622055
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.00769231	0.76470565622055
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.00769231	0.76470565622055
NAXOS DISEASE	0.00769231	0.76470565622055
PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1	0.00769231	0.76470565622055
FAMILIAL TUMORAL CALCINOSIS	0.00769231	0.76470565622055
ADRENOCORTICAL CARCINOMA	0.00769231	0.76470565622055
ACHONDROPLASIA	0.00769231	0.76470565622055
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.00769231	0.76470565622055
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.00769231	0.76470565622055
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.00769231	0.76470565622055
MAL DE MELEDA	0.00769231	0.76470565622055
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00769231	0.76470565622055
PEELING SKIN SYNDROME	0.00769231	0.76470565622055
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00769231	0.76470565622055
PARAGANGLIOMAS 3	0.00769231	0.76470565622055
PACHYONYCHIA CONGENITA	0.00769231	0.76470565622055
KASABACH-MERRITT SYNDROME	0.00769231	0.76470565622055
MONOSOMY 22	0.00769231	0.76470565622055
HYPERHIDROSIS, GUSTATORY	0.00769231	0.76470565622055
GRANULOSIS RUBRA NASI	0.00769231	0.76470565622055
PERIPHERAL MOTOR NEUROPATHY-DYSAUTONOMIA SYNDROME	0.00769231	0.76470565622055
MAL DE MELEDA	0.00769231	0.76470565622055
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.00769231	0.76470565622055
ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS	0.00769231	0.76470565622055
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.00769231	0.76470565622055
ACROKERATOELASTOIDOSIS OF COSTA	0.00769231	0.76470565622055
PHEOCHROMOCYTOMA	0.00769231	0.76470565622055
BLOOM SYNDROME	0.00769231	0.76470565622055
X-LINKED ACROGIGANTISM	0.00769231	0.76470565622055
BÖÖK SYNDROME	0.00769231	0.76470565622055
PITUITARY GIGANTISM	0.00769231	0.76470565622055
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00769231	0.76470565622055
NAKAJO-NISHIMURA SYNDROME	0.00769231	0.76470565622055
STIFF-PERSON SYNDROME; SPS	0.00769231	0.76470565622055
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.00769231	0.76470565622055
MEDULLARY THYROID CARCINOMA	0.00769231	0.76470565622055
ISAAC SYNDROME	0.00769231	0.76470565622055
PARAGANGLIOMAS 1	0.00769231	0.76470565622055
BUERGER DISEASE	0.00769231	0.76470565622055
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00769231	0.76470565622055
TRANSGREDIENS ET PROGREDIENS PALMOPLANTAR KERATODERMA	0.00769231	0.76470565622055
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00769231	0.76470565622055
PARAGANGLIOMAS 4	0.00769231	0.76470565622055
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.007658949	0.7613891823138595
ADDISON DISEASE	0.007658949	0.7613891823138595
ACUTE ADRENAL INSUFFICIENCY	0.007658949	0.7613891823138595
GITELMAN SYNDROME	0.007658949	0.7613891823138595
PORPHYRIA	0.007658949	0.7613891823138595
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007658949	0.7613891823138595
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.007617545	0.7572731400599519
BRITTLE CORNEA SYNDROME	0.007617545	0.7572731400599519
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.007617545	0.7572731400599519
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.007617545	0.7572731400599519
MARSHALL-SMITH SYNDROME	0.007617545	0.7572731400599519
LOEYS-DIETZ SYNDROME	0.007617545	0.7572731400599519
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.007617545	0.7572731400599519
ANGELMAN SYNDROME	0.007577014	0.753243884224933
SSR4-CDG	0.007551794	0.7507367210125973
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.007551794	0.7507367210125973
14Q12 MICRODELETION SYNDROME	0.007551794	0.7507367210125973
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007551794	0.7507367210125973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00741758	0.737394278372612
NK-CELL ENTEROPATHY	0.00741758	0.737394278372612
COFFIN-SIRIS SYNDROME 6; CSS6	0.00741758	0.737394278372612
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.0073922499999999995	0.7348761798726728
REYNOLDS SYNDROME	0.0073922499999999995	0.7348761798726728
STICKLER SYNDROME	0.0073103149999999995	0.7267308817837462
SHPRINTZEN-GOLDBERG SYNDROME	0.0073103149999999995	0.7267308817837462
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.0073103149999999995	0.7267308817837462
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.007277074	0.7234263372817141
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.007277074	0.7234263372817141
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.007277074	0.7234263372817141
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.007277074	0.7234263372817141
CHÉDIAK-HIGASHI SYNDROME	0.007163938999999999	0.7121793939816505
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.007163938999999999	0.7121793939816505
BOTULISM	0.00711753	0.7075657961417898
ADIPOSIS DOLOROSA	0.00711753	0.7075657961417898
JUVENILE DERMATOMYOSITIS	0.00711753	0.7075657961417898
THYROID HEMIAGENESIS	0.00711753	0.7075657961417898
THYROID HYPOPLASIA	0.00711753	0.7075657961417898
LIDDLE SYNDROME	0.00711753	0.7075657961417898
FAMILIAL THYROID DYSHORMONOGENESIS	0.00711753	0.7075657961417898
IATROGENIC BOTULISM	0.00711753	0.7075657961417898
PANHYPOPITUITARISM	0.00711753	0.7075657961417898
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00711753	0.7075657961417898
GASTROINTESTINAL STROMAL TUMOR	0.00711753	0.7075657961417898
INHALATIONAL BOTULISM	0.00711753	0.7075657961417898
POPOV-CHANG SYNDROME; POPCHAS	0.007010374999999999	0.6969133348405274
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.007010374999999999	0.6969133348405274
BAKER-GORDON SYNDROME; BAGOS	0.007010374999999999	0.6969133348405274
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.007010374999999999	0.6969133348405274
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.007010374999999999	0.6969133348405274
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.007010374999999999	0.6969133348405274
AICARDI-GOUTIÈRES SYNDROME	0.006912784	0.6872116470905253
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.006856709	0.6816371357054449
CORNELIA DE LANGE SYNDROME 3	0.006856709	0.6816371357054449
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.006856709	0.6816371357054449
BRANCHIOOCULOFACIAL SYNDROME	0.006856709	0.6816371357054449
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.006735655	0.6696029511096444
AU-KLINE SYNDROME; AUKS	0.006735655	0.6696029511096444
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.00662252	0.6583560078095808
%605735 BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12;;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 DEFICIENCY, PLATELET;;PGHS1 DEFICIENCY;;PLATELET CYCLOOXYGENASE 1 DEFICIENCY;;PLATELET COX1 DEFICIENCY	0.00662252	0.6583560078095808
PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	0.00662252	0.6583560078095808
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00662252	0.6583560078095808
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00662252	0.6583560078095808
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	0.00662252	0.6583560078095808
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00662252	0.6583560078095808
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00662252	0.6583560078095808
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00662252	0.6583560078095808
PURPURA SIMPLEX	0.00662252	0.6583560078095808
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00662252	0.6583560078095808
IMMUNE THROMBOCYTOPENIC PURPURA	0.00662252	0.6583560078095808
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00662252	0.6583560078095808
THROMBOCYTOPENIA 2	0.00662252	0.6583560078095808
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00662252	0.6583560078095808
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00662252	0.6583560078095808
168830 PASSOVOY FACTOR DEFECT	0.00662252	0.6583560078095808
176630 PRIMARY RELEASE DISORDER OF PLATELETS	0.00662252	0.6583560078095808
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00662252	0.6583560078095808
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00662252	0.6583560078095808
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.00662252	0.6583560078095808
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.00662252	0.6583560078095808
PLASMIN INHIBITOR DEFICIENCY	0.00662252	0.6583560078095808
THROMBOCYTOPENIA 5; THC5	0.00662252	0.6583560078095808
CONGENITAL PROTHROMBIN DEFICIENCY	0.00662252	0.6583560078095808
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.00662252	0.6583560078095808
BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	0.00662252	0.6583560078095808
WILSON DISEASE	0.00662252	0.6583560078095808
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN IA DEFICIENCY;;GP IA DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00662252	0.6583560078095808
FACTOR V DEFICIENCY	0.00662252	0.6583560078095808
FANCONI ANEMIA	0.00662252	0.6583560078095808
KAPOSIFORM LYMPHANGIOMATOSIS	0.00662252	0.6583560078095808
GLANZMANN THROMBASTHENIA	0.00662252	0.6583560078095808
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00662252	0.6583560078095808
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00662252	0.6583560078095808
BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14	0.00662252	0.6583560078095808
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00662252	0.6583560078095808
EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTINABNORMALITY	0.00662252	0.6583560078095808
ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	0.00662252	0.6583560078095808
CONGENITAL FACTOR V DEFICIENCY	0.00662252	0.6583560078095808
GRAY PLATELET SYNDROME	0.00662252	0.6583560078095808
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00662252	0.6583560078095808
CONGENITAL FACTOR XIII DEFICIENCY	0.00662252	0.6583560078095808
HEMOPHILIA A	0.00662252	0.6583560078095808
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.00662252	0.6583560078095808
ACQUIRED VON WILLEBRAND SYNDROME	0.00662252	0.6583560078095808
FACTOR XIII, A SUBUNIT, DEFICIENCY OF	0.00662252	0.6583560078095808
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00662252	0.6583560078095808
CONGENITAL FACTOR X DEFICIENCY	0.00662252	0.6583560078095808
EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE	0.00662252	0.6583560078095808
FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF	0.00662252	0.6583560078095808
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00662252	0.6583560078095808
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.00662252	0.6583560078095808
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00662252	0.6583560078095808
CONGENITAL FACTOR VII DEFICIENCY	0.00662252	0.6583560078095808
EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE	0.00662252	0.6583560078095808
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00662252	0.6583560078095808
HEMOPHILIA A WITH VASCULAR ABNORMALITY	0.00662252	0.6583560078095808
FECHTNER SYNDROME	0.00662252	0.6583560078095808
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION	0.00662252	0.6583560078095808
CONGENITAL FIBRINOGEN DEFICIENCY	0.00662252	0.6583560078095808
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00662252	0.6583560078095808
BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	0.00662252	0.6583560078095808
CONGENITAL ALPHA2-ANTIPLASMIN DEFICIENCY	0.00662252	0.6583560078095808
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00662252	0.6583560078095808
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.00662252	0.6583560078095808
FACTOR XIII, B SUBUNIT, DEFICIENCY OF	0.00662252	0.6583560078095808
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00662252	0.6583560078095808
ARTERIAL TORTUOSITY SYNDROME	0.00662252	0.6583560078095808
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00662252	0.6583560078095808
MYH9-RELATED DISEASE	0.00662252	0.6583560078095808
GAUCHER DISEASE TYPE 1	0.00662252	0.6583560078095808
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.006556769	0.651819588762226
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.006556769	0.651819588762226
MENTAL RETARDATION, X-LINKED 98; MRX98	0.006556769	0.651819588762226
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.006556769	0.651819588762226
WIEDEMANN-STEINER SYNDROME	0.006556769	0.651819588762226
GENITOPATELLAR SYNDROME	0.006556769	0.651819588762226
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.006556769	0.651819588762226
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.006556768999999999	0.651819588762226
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.006556768999999999	0.651819588762226
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.006556768999999999	0.651819588762226
CHIARI MALFORMATION TYPE I	0.006371365	0.6333882609184555
CAMURATI-ENGELMANN DISEASE	0.006371365	0.6333882609184555
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.0063152899999999994	0.6278137495333751
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.0063152899999999994	0.6278137495333751
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.006282049	0.624509205031343
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.006282049	0.624509205031343
NEPHROGENIC DIABETES INSIPIDUS	0.006282049	0.624509205031343
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006282049	0.624509205031343
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.006282049	0.624509205031343
CHROMOSOME 19P13.13 DELETION SYNDROME	0.006282049	0.624509205031343
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006282049	0.624509205031343
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.006256718999999999	0.6219911065314038
CHOREOACANTHOCYTOSIS	0.006256718999999999	0.6219911065314038
COCKAYNE SYNDROME	0.006256718999999999	0.6219911065314038
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.006174783999999999	0.6138458084424772
17Q24.2 MICRODELETION SYNDROME	0.006174783999999999	0.6138458084424772
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.006174783999999999	0.6138458084424772
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.006174783999999999	0.6138458084424772
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.006174783999999999	0.6138458084424772
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.006174783999999999	0.6138458084424772
16Q24.3 MICRODELETION SYNDROME	0.006174783999999999	0.6138458084424772
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00604057	0.6005033658024921
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.006015349999999999	0.5979962025901562
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.006015349999999999	0.5979962025901562
16P13.11 MICRODELETION SYNDROME	0.006015349999999999	0.5979962025901562
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.006015349999999999	0.5979962025901562
MEIER-GORLIN SYNDROME 6; MGORS6	0.006015349999999999	0.5979962025901562
16P11.2P12.2 MICRODELETION SYNDROME	0.006015349999999999	0.5979962025901562
MEIER-GORLIN SYNDROME 5; MGORS5	0.006015349999999999	0.5979962025901562
ISOTRETINOIN-LIKE SYNDROME	0.006015349999999999	0.5979962025901562
HOLMES-GANG SYNDROME	0.006015349999999999	0.5979962025901562
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.006015349999999999	0.5979962025901562
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.006015349999999999	0.5979962025901562
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.006015349999999999	0.5979962025901562
NATIVE AMERICAN MYOPATHY	0.006015349999999999	0.5979962025901562
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.006015349999999999	0.5979962025901562
SENGERS SYNDROME	0.00601524	0.597985267302553
SNEDDON SYNDROME	0.005917759	0.588294514840154
CRANIOPHARYNGIOMA	0.005917759	0.588294514840154
CENTRAL DIABETES INSIPIDUS	0.005917759	0.588294514840154
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.005917759	0.588294514840154
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.005917759	0.588294514840154
NEUROFIBROMATOSIS, TYPE II	0.005917759	0.588294514840154
WYBURN-MASON SYNDROME	0.005917759	0.588294514840154
ABETA AMYLOIDOSIS, DUTCH TYPE	0.005917759	0.588294514840154
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.005917759	0.588294514840154
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.005917759	0.588294514840154
NARP SYNDROME	0.005917759	0.588294514840154
POSTENCEPHALITIC PARKINSONISM	0.005917759	0.588294514840154
ROSAÏ-DORFMAN DISEASE	0.005917759	0.588294514840154
PINEOBLASTOMA	0.005917759	0.588294514840154
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.005917759	0.588294514840154
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.005917759	0.588294514840154
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.005917759	0.588294514840154
PARIETAL FORAMINA	0.005917759	0.588294514840154
L1 SYNDROME	0.005917759	0.588294514840154
PAPILLOMA OF CHOROID PLEXUS	0.005917759	0.588294514840154
LHERMITTE-DUCLOS DISEASE	0.005917759	0.588294514840154
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.005917759	0.588294514840154
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.005917759	0.588294514840154
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.005917759	0.588294514840154
ENCEPHALITIS LETHARGICA	0.005917759	0.588294514840154
OPTIC PATHWAY GLIOMA	0.005917759	0.588294514840154
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00574063	0.5706858188592732
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00574063	0.5706858188592732
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00574063	0.5706858188592732
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00574063	0.5706858188592732
COFFIN-SIRIS SYNDROME 7; CSS7	0.00574063	0.5706858188592732
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00574063	0.5706858188592732
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00574063	0.5706858188592732
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0057152999999999995	0.568167720359334
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0057152999999999995	0.568167720359334
HAREL-YOON SYNDROME; HAYOS	0.0056333649999999996	0.5600224222704074
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0056333649999999996	0.5600224222704074
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0056333649999999996	0.5600224222704074
CODAS SYNDROME	0.005382594	0.5350928494741886
SMITH-LEMLI-OPITZ SYNDROME	0.005382594	0.5350928494741886
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005382594	0.5350928494741886
POTOCKI-LUPSKI SYNDROME	0.005382594	0.5350928494741886
PITT-HOPKINS-LIKE SYNDROME	0.005382594	0.5350928494741886
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.005382594	0.5350928494741886
CROUZON DISEASE	0.00537634	0.5344711286680843
ADENOHYPOPHYSITIS	0.00537634	0.5344711286680843
PANHYPOPHYSITIS	0.00537634	0.5344711286680843
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00537634	0.5344711286680843
PARKES WEBER SYNDROME	0.00537634	0.5344711286680843
RAT-BITE FEVER	0.00537634	0.5344711286680843
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.5344711286680843
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00537634	0.5344711286680843
MEDULLOBLASTOMA	0.00537634	0.5344711286680843
SECONDARY POLYCYTHEMIA	0.00537634	0.5344711286680843
PERINEURAL CYST	0.00537634	0.5344711286680843
SCLEROSTEOSIS 1; SOST1	0.00537634	0.5344711286680843
MALARIA	0.00537634	0.5344711286680843
HYPER-IGD SYNDROME	0.00537634	0.5344711286680843
RHABDOID TUMOR	0.00537634	0.5344711286680843
INTERNAL CAROTID AGENESIS	0.00537634	0.5344711286680843
SYDENHAM CHOREA	0.00537634	0.5344711286680843
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00537634	0.5344711286680843
PAROXYSMAL COLD HEMOGLOBINURIA	0.00537634	0.5344711286680843
PITUITARY CARCINOMA	0.00537634	0.5344711286680843
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00537634	0.5344711286680843
AMERICAN TRYPANOSOMIASIS	0.00537634	0.5344711286680843
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00537634	0.5344711286680843
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.5344711286680843
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00537634	0.5344711286680843
LEPTOSPIROSIS	0.00537634	0.5344711286680843
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.5344711286680843
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00537634	0.5344711286680843
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00537634	0.5344711286680843
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.5344711286680843
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00537634	0.5344711286680843
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.5344711286680843
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.5344711286680843
YELLOW FEVER	0.00537634	0.5344711286680843
EPISODIC ATAXIA, TYPE 3	0.00537634	0.5344711286680843
THYMIC TUMOR	0.00537634	0.5344711286680843
X-LINKED ADRENOLEUKODYSTROPHY	0.00537634	0.5344711286680843
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00537634	0.5344711286680843
MANGANESE POISONING	0.00537634	0.5344711286680843
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.00537634	0.5344711286680843
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.5344711286680843
HEMANGIOBLASTOMA	0.00537634	0.5344711286680843
SUSAC SYNDROME	0.00537634	0.5344711286680843
BENIGN OCCIPITAL EPILEPSY	0.00537634	0.5344711286680843
PINEOCYTOMA	0.00537634	0.5344711286680843
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00537634	0.5344711286680843
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.5344711286680843
CENTRAL NEUROCYTOMA	0.00537634	0.5344711286680843
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.5344711286680843
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.5344711286680843
PREECLAMPSIA	0.00537634	0.5344711286680843
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00537634	0.5344711286680843
MENINGIOMA	0.00537634	0.5344711286680843
CUTANEOUS MASTOCYTOMA	0.00537634	0.5344711286680843
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.5344711286680843
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.5344711286680843
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.5344711286680843
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.5344711286680843
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.5344711286680843
SOLAR URTICARIA	0.00537634	0.5344711286680843
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.5344711286680843
HYDROXYKYNURENINURIA	0.00537634	0.5344711286680843
IDIOPATHIC PANUVEITIS	0.00537634	0.5344711286680843
TEMPI SYNDROME	0.00537634	0.5344711286680843
MAJEED SYNDROME	0.00537634	0.5344711286680843
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00537634	0.5344711286680843
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.5344711286680843
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.005179758999999999	0.514928676192106
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.005179758999999999	0.514928676192106
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.005179758999999999	0.514928676192106
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.005179758999999999	0.514928676192106
11Q22.2Q22.3 MICRODELETION SYNDROME	0.005179758999999999	0.514928676192106
KAPUR-TORIELLO SYNDROME	0.005107874	0.5077824657433054
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.005107874	0.5077824657433054
HOLOPROSENCEPHALY 2; HPE2	0.005107874	0.5077824657433054
ATYPICAL JUVENILE PARKINSONISM	0.005082544	0.5052643672433662
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.004841175	0.48126946330211867
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.004841175	0.48126946330211867
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.004841175	0.48126946330211867
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.004841175	0.48126946330211867
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.004841175	0.48126946330211867
FOCAL DERMAL HYPOPLASIA	0.004841175	0.48126946330211867
17P11.2 MICRODUPLICATION SYNDROME	0.004841175	0.48126946330211867
17Q23.1Q23.2 MICRODELETION SYNDROME	0.004841175	0.48126946330211867
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.004841175	0.48126946330211867
3C SYNDROME	0.004841175	0.48126946330211867
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.004841175	0.48126946330211867
CRANIOLENTICULOSUTURAL DYSPLASIA	0.004841175	0.48126946330211867
LYMPHEDEMA, HEREDITARY, III	0.004841175	0.48126946330211867
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.004841175	0.48126946330211867
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0046383399999999995	0.4611052900200363
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0046383399999999995	0.4611052900200363
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0046383399999999995	0.4611052900200363
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0046383399999999995	0.4611052900200363
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0046383399999999995	0.4611052900200363
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.0045664550000000005	0.45395907957123566
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.0045664550000000005	0.45395907957123566
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.004541125	0.4514409810712965
HEART AND BRAIN MALFORMATION SYNDROME	0.004387569	0.4361757172238173
FRYNS SYNDROME	0.004387569	0.4361757172238173
HEREDITARY HYPEREKPLEXIA	0.004387569	0.4361757172238173
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.004387569	0.4361757172238173
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.004387569	0.4361757172238173
SEVERE CANAVAN DISEASE	0.004387569	0.4361757172238173
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.004387569	0.4361757172238173
CANAVAN DISEASE	0.004387569	0.4361757172238173
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.004387569	0.4361757172238173
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.004387569	0.4361757172238173
ATYPICAL RETT SYNDROME	0.004387569	0.4361757172238173
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004387569	0.4361757172238173
WEBB-DATTANI SYNDROME; WEDAS	0.004387569	0.4361757172238173
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.004387569	0.4361757172238173
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.004387569	0.4361757172238173
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.004387569	0.4361757172238173
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.004387569	0.4361757172238173
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.004387569	0.4361757172238173
FRAGILE X SYNDROME	0.004387569	0.4361757172238173
HADDAD SYNDROME	0.004387569	0.4361757172238173
1Q21.1 MICRODUPLICATION SYNDROME	0.004387569	0.4361757172238173
8Q24.3 MICRODELETION SYNDROME	0.004387569	0.4361757172238173
KLEEFSTRA SYNDROME	0.004387569	0.4361757172238173
TRISOMY 8P	0.004112849	0.40886533349293425
RUBINSTEIN-TAYBI SYNDROME	0.004112849	0.40886533349293425
PORPHYRIA VARIEGATA	0.004112849	0.40886533349293425
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.004112849	0.40886533349293425
HEREDITARY COPROPORPHYRIA	0.004112849	0.40886533349293425
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.004112849	0.40886533349293425
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.40886533349293425
MOWAT-WILSON SYNDROME; MOWS	0.004112849	0.40886533349293425
MOWAT-WILSON SYNDROME	0.004112849	0.40886533349293425
WIEDEMANN-STEINER SYNDROME; WDSTS	0.004112849	0.40886533349293425
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.004112849	0.40886533349293425
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004112849	0.40886533349293425
9Q33.3Q34.11 MICRODELETION SYNDROME	0.004112849	0.40886533349293425
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.004112849	0.40886533349293425
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.004112849	0.40886533349293425
2Q23.1 MICRODELETION SYNDROME	0.004112849	0.40886533349293425
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004112849	0.40886533349293425
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.40886533349293425
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004112849	0.40886533349293425
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.40886533349293425
HYPOPHOSPHATASIA, INFANTILE	0.004112849	0.40886533349293425
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.40886533349293425
TEMPLE-BARAITSER SYNDROME	0.004112849	0.40886533349293425
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.0040875189999999995	0.4063472349929951
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.0040875189999999995	0.4063472349929951
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0040875189999999995	0.4063472349929951
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.0040875189999999995	0.4063472349929951
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.0040875189999999995	0.4063472349929951
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0040875189999999995	0.4063472349929951
XERODERMA PIGMENTOSUM	0.0040875189999999995	0.4063472349929951
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0040875189999999995	0.4063472349929951
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0040875189999999995	0.4063472349929951
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0040875189999999995	0.4063472349929951
WHIPPLE DISEASE	0.0040875189999999995	0.4063472349929951
CRONKHITE-CANADA SYNDROME	0.0040875189999999995	0.4063472349929951
LYMPHANGIOLEIOMYOMATOSIS	0.0040875189999999995	0.4063472349929951
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.0040875189999999995	0.4063472349929951
COFFIN-SIRIS SYNDROME 1; CSS1	0.0040055839999999995	0.3982019369040685
SJÖGREN-LARSSON SYNDROME	0.0040055839999999995	0.3982019369040685
FOUNTAIN SYNDROME	0.0040055839999999995	0.3982019369040685
MUCOPOLYSACCHARIDOSIS TYPE 3	0.0040055839999999995	0.3982019369040685
CHROMOSOME 16P13.3 DELETION SYNDROME	0.0040055839999999995	0.3982019369040685
ZIMMERMANN-LABAND SYNDROME 1	0.0040055839999999995	0.3982019369040685
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0040055839999999995	0.3982019369040685
COWDEN SYNDROME 5; CWS5	0.0040055839999999995	0.3982019369040685
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.0040055839999999995	0.3982019369040685
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.0040055839999999995	0.3982019369040685
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0040055839999999995	0.3982019369040685
PROTEUS SYNDROME	0.0040055839999999995	0.3982019369040685
TARP SYNDROME	0.0040055839999999995	0.3982019369040685
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0040055839999999995	0.3982019369040685
COWDEN SYNDROME 6; CWS6	0.0040055839999999995	0.3982019369040685
PETERS-PLUS SYNDROME; PTRPLS	0.0040055839999999995	0.3982019369040685
COHEN SYNDROME	0.0040055839999999995	0.3982019369040685
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0040055839999999995	0.3982019369040685
19P13.12 MICRODELETION SYNDROME	0.0040055839999999995	0.3982019369040685
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0040055839999999995	0.3982019369040685
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.0040055839999999995	0.3982019369040685
PRADER-WILLI SYNDROME; PWS	0.0040055839999999995	0.3982019369040685
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.0040055839999999995	0.3982019369040685
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00384615	0.38235233105174754
TURNPENNY-FRY SYNDROME; TPFS	0.00384615	0.38235233105174754
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00384615	0.38235233105174754
MEIER-GORLIN SYNDROME 1; MGORS1	0.00384615	0.38235233105174754
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00384615	0.38235233105174754
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00384615	0.38235233105174754
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00384615	0.38235233105174754
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00384615	0.38235233105174754
EOSINOPHILIC ESOPHAGITIS	0.00384615	0.38235233105174754
ISOLATED POLYCYSTIC LIVER DISEASE	0.00384615	0.38235233105174754
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00384615	0.38235233105174754
TOWNES-BROCKS SYNDROME 1; TBS1	0.00384615	0.38235233105174754
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00384615	0.38235233105174754
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00384615	0.38235233105174754
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00384615	0.38235233105174754
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00384615	0.38235233105174754
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.38235233105174754
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00384615	0.38235233105174754
COSTELLO SYNDROME	0.00384615	0.38235233105174754
CARCINOMA OF ESOPHAGUS	0.00384615	0.38235233105174754
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00384615	0.38235233105174754
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00384615	0.38235233105174754
GASTROESOPHAGEAL REFLUX	0.00384615	0.38235233105174754
2Q23.1 MICRODUPLICATION SYNDROME	0.00384615	0.38235233105174754
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00384615	0.38235233105174754
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.38235233105174754
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00384615	0.38235233105174754
MÉNÉTRIER DISEASE	0.00384615	0.38235233105174754
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00384615	0.38235233105174754
ADENOCARCINOMA OF THE ESOPHAGUS	0.00384615	0.38235233105174754
3Q29 MICRODELETION SYNDROME	0.00384615	0.38235233105174754
8Q12 MICRODUPLICATION SYNDROME	0.00384615	0.38235233105174754
SWEENEY-COX SYNDROME; SWCOS	0.00384615	0.38235233105174754
CHRONIC GRAFT VERSUS HOST DISEASE	0.00384615	0.38235233105174754
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00384615	0.38235233105174754
CHRISTIANSON SYNDROME	0.00384615	0.38235233105174754
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00384615	0.38235233105174754
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00384615	0.38235233105174754
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00384615	0.38235233105174754
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00384615	0.38235233105174754
PIERPONT SYNDROME	0.0037056439999999997	0.36838438996084966
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.0037056439999999997	0.36838438996084966
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0037056439999999997	0.36838438996084966
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0037056439999999997	0.36838438996084966
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0037056439999999997	0.36838438996084966
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0037056439999999997	0.36838438996084966
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0037056439999999997	0.36838438996084966
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0037056439999999997	0.36838438996084966
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0037056439999999997	0.36838438996084966
WIEACKER-WOLFF SYNDROME	0.0037056439999999997	0.36838438996084966
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0037056439999999997	0.36838438996084966
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0037056439999999997	0.36838438996084966
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0037056439999999997	0.36838438996084966
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0037056439999999997	0.36838438996084966
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.0037056439999999997	0.36838438996084966
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0037056439999999997	0.36838438996084966
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0037056439999999997	0.36838438996084966
JOUBERT SYNDROME WITH RENAL DEFECT	0.0037056439999999997	0.36838438996084966
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0037056439999999997	0.36838438996084966
COFFIN-SIRIS SYNDROME 3; CSS3	0.0037056439999999997	0.36838438996084966
COFFIN-SIRIS SYNDROME 4; CSS4	0.0037056439999999997	0.36838438996084966
KBG SYNDROME	0.0037056439999999997	0.36838438996084966
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0037056439999999997	0.36838438996084966
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0037056439999999997	0.36838438996084966
KABUKI SYNDROME	0.0037056439999999997	0.36838438996084966
KAPUR-TORIELLO SYNDROME	0.00357143	0.35504194732086447
PUDENDAL NEURALGIA	0.00357143	0.35504194732086447
NEUROFERRITINOPATHY	0.00357143	0.35504194732086447
THYROID ECTOPIA	0.00357143	0.35504194732086447
300270 ADRENOMYODYSTROPHY	0.00357143	0.35504194732086447
FOODBORNE BOTULISM	0.00357143	0.35504194732086447
FG SYNDROME 2; FGS2	0.00357143	0.35504194732086447
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.35504194732086447
FLOATING-HARBOR SYNDROME	0.00357143	0.35504194732086447
HIRSCHSPRUNG DISEASE	0.00357143	0.35504194732086447
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.35504194732086447
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.35504194732086447
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.35504194732086447
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00357143	0.35504194732086447
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00357143	0.35504194732086447
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00357143	0.35504194732086447
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.35504194732086447
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00357143	0.35504194732086447
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00357143	0.35504194732086447
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.35504194732086447
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.35504194732086447
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00357143	0.35504194732086447
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.35504194732086447
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.35504194732086447
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.35504194732086447
ANAL SPHINCTER DYSPLASIA; ASDP	0.00357143	0.35504194732086447
INFANT BOTULISM	0.00357143	0.35504194732086447
WOUND BOTULISM	0.00357143	0.35504194732086447
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.35504194732086447
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00357143	0.35504194732086447
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.35504194732086447
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.35504194732086447
TOWNES-BROCKS SYNDROME	0.00357143	0.35504194732086447
ATTRV30M AMYLOIDOSIS	0.00357143	0.35504194732086447
VISCERAL MYOPATHY; VSCM	0.00357143	0.35504194732086447
PPOMA	0.00357143	0.35504194732086447
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.35504194732086447
CONGENITAL HYPOTHYROIDISM	0.00357143	0.35504194732086447
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.35504194732086447
NIEMANN-PICK DISEASE, TYPE A	0.00357143	0.35504194732086447
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.35504194732086447
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.35504194732086447
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.35504194732086447
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.35504194732086447
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00357143	0.35504194732086447
WAARDENBURG-SHAH SYNDROME	0.00357143	0.35504194732086447
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.00357143	0.35504194732086447
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.35504194732086447
PSEUDOMYXOMA PERITONEI	0.00357143	0.35504194732086447
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.35504194732086447
CAP POLYPOSIS	0.00357143	0.35504194732086447
PORPHYRIA VARIEGATA	0.00357143	0.35504194732086447
MULTIPLE SYSTEM ATROPHY	0.00357143	0.35504194732086447
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.35504194732086447
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.35504194732086447
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.35504194732086447
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.35504194732086447
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.35504194732086447
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.35252384882092536
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.0035461	0.35252384882092536
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.0035461	0.35252384882092536
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.0035461	0.35252384882092536
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0035461	0.35252384882092536
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0035461	0.35252384882092536
STEVENS-JOHNSON SYNDROME	0.0035461	0.35252384882092536
DERMATOMYOSITIS	0.0035461	0.35252384882092536
THYMOMA	0.0035461	0.35252384882092536
SCHNITZLER SYNDROME	0.0035461	0.35252384882092536
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0035461	0.35252384882092536
RARE HEREDITARY HEMOCHROMATOSIS	0.0035461	0.35252384882092536
LEISHMANIASIS	0.0035461	0.35252384882092536
ADULT-ONSET STILL DISEASE	0.0035461	0.35252384882092536
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.0035461	0.35252384882092536
PRIMARY SCLEROSING CHOLANGITIS	0.0035461	0.35252384882092536
CHOLANGIOCARCINOMA	0.0035461	0.35252384882092536
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.35252384882092536
KUFOR-RAKEB SYNDROME	0.0035461	0.35252384882092536
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.35252384882092536
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0035461	0.35252384882092536
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.35252384882092536
POSTPOLIOMYELITIS SYNDROME	0.0035461	0.35252384882092536
INHALATIONAL ANTHRAX	0.0035461	0.35252384882092536
MULTIPLE MYELOMA	0.0035461	0.35252384882092536
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.0035461	0.35252384882092536
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0035461	0.35252384882092536
X-LINKED SIDEROBLASTIC ANEMIA	0.0035461	0.35252384882092536
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0035461	0.35252384882092536
GAUCHER DISEASE TYPE 3	0.0035461	0.35252384882092536
PITUITARY APOPLEXY	0.0035461	0.35252384882092536
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0035461	0.35252384882092536
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0035461	0.35252384882092536
AL AMYLOIDOSIS	0.0035461	0.35252384882092536
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.0035461	0.35252384882092536
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.0035461	0.35252384882092536
EISENMENGER SYNDROME	0.0035461	0.35252384882092536
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0035461	0.35252384882092536
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.35252384882092536
PRIMARY BILIARY CHOLANGITIS	0.0035461	0.35252384882092536
CYCLIC NEUTROPENIA	0.0035461	0.35252384882092536
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0035461	0.35252384882092536
PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.35252384882092536
PRIMARY MYELOFIBROSIS	0.0035461	0.35252384882092536
HEPATOCELLULAR CARCINOMA	0.0035461	0.35252384882092536
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.35252384882092536
LIPOSARCOMA	0.0035461	0.35252384882092536
CASTLEMAN DISEASE	0.0035461	0.35252384882092536
POST-TRAUMATIC PITUITARY DEFICIENCY	0.0035461	0.35252384882092536
KIKUCHI-FUJIMOTO DISEASE	0.0035461	0.35252384882092536
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0035461	0.35252384882092536
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.35252384882092536
CHRONIC MYELOID LEUKEMIA	0.0035461	0.35252384882092536
BECKER MUSCULAR DYSTROPHY	0.0035461	0.35252384882092536
THYMIC EPITHELIAL NEOPLASM	0.0035461	0.35252384882092536
MANTLE CELL LYMPHOMA	0.0035461	0.35252384882092536
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.0035461	0.35252384882092536
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0035461	0.35252384882092536
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.0035461	0.35252384882092536
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.35252384882092536
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.35252384882092536
TOXIC EPIDERMAL NECROLYSIS	0.0035461	0.35252384882092536
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.35252384882092536
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0035461	0.35252384882092536
FOLLICULAR LYMPHOMA	0.0035461	0.35252384882092536
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.35252384882092536
PERIPARTUM CARDIOMYOPATHY	0.0035461	0.35252384882092536
REFRACTORY ANEMIA	0.0035461	0.35252384882092536
MUCOLIPIDOSIS TYPE III	0.0035461	0.35252384882092536
MACROPHAGIC MYOFASCIITIS	0.0035461	0.35252384882092536
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0035461	0.35252384882092536
EOSINOPHILIC FASCIITIS	0.0035461	0.35252384882092536
DUBIN-JOHNSON SYNDROME	0.0035461	0.35252384882092536
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.0035461	0.35252384882092536
MAST CELL SARCOMA	0.0035461	0.35252384882092536
CYSTINOSIS	0.0035461	0.35252384882092536
KLATSKIN TUMOR	0.0035461	0.35252384882092536
GAMMA-HEAVY CHAIN DISEASE	0.0035461	0.35252384882092536
HEMOCHROMATOSIS, TYPE 4; HFE4	0.0035461	0.35252384882092536
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0035461	0.35252384882092536
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0035461	0.35252384882092536
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0035461	0.35252384882092536
BARTH SYNDROME; BTHS	0.0035461	0.35252384882092536
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.0035461	0.35252384882092536
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.0035461	0.35252384882092536
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.0035461	0.35252384882092536
SATOYOSHI SYNDROME	0.0035461	0.35252384882092536
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0035461	0.35252384882092536
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.0035461	0.35252384882092536
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0035461	0.35252384882092536
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0035461	0.35252384882092536
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.0035461	0.35252384882092536
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.35252384882092536
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0035461	0.35252384882092536
ANISOCORIA	0.0035461	0.35252384882092536
BRITTLE CORNEA SYNDROME	0.003464165	0.34437855073199874
KNIEST DYSPLASIA	0.003464165	0.34437855073199874
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.003464165	0.34437855073199874
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003464165	0.34437855073199874
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.003464165	0.34437855073199874
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.003464165	0.34437855073199874
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.003464165	0.34437855073199874
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.003464165	0.34437855073199874
POLAND SYNDROME	0.003464165	0.34437855073199874
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.003464165	0.34437855073199874
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.003464165	0.34437855073199874
MEIER-GORLIN SYNDROME 7	0.003464165	0.34437855073199874
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.003464165	0.34437855073199874
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.003464165	0.34437855073199874
HUNTER-MACDONALD SYNDROME	0.003464165	0.34437855073199874
LAMB-SHAFFER SYNDROME	0.003464165	0.34437855073199874
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.003464165	0.34437855073199874
COHEN-GIBSON SYNDROME; COGIS	0.003464165	0.34437855073199874
MUCOLIPIDOSIS III GAMMA	0.003464165	0.34437855073199874
DESBUQUOIS DYSPLASIA 1	0.003464165	0.34437855073199874
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.003464165	0.34437855073199874
CARTILAGE-HAIR HYPOPLASIA	0.003464165	0.34437855073199874
TURNER SYNDROME	0.003464165	0.34437855073199874
STICKLER SYNDROME, TYPE I	0.003464165	0.34437855073199874
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.003464165	0.34437855073199874
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.003464165	0.34437855073199874
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.003464165	0.34437855073199874
MONOSOMY X	0.003464165	0.34437855073199874
CHROMOSOME 9P DELETION SYNDROME	0.003464165	0.34437855073199874
MARFANOID HABITUS WITH SITUS INVERSUS	0.003464165	0.34437855073199874
MOSAIC MONOSOMY X	0.003464165	0.34437855073199874
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0031642249999999997	0.31456100378877994
STUVE-WIEDEMANN SYNDROME	0.0031642249999999997	0.31456100378877994
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0031642249999999997	0.31456100378877994
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0031642249999999997	0.31456100378877994
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0031642249999999997	0.31456100378877994
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0031642249999999997	0.31456100378877994
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0031642249999999997	0.31456100378877994
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0031642249999999997	0.31456100378877994
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0031642249999999997	0.31456100378877994
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0031642249999999997	0.31456100378877994
CHARGE SYNDROME	0.0031642249999999997	0.31456100378877994
NEMALINE MYOPATHY 2; NEM2	0.0031642249999999997	0.31456100378877994
2P15P16.1 MICRODELETION SYNDROME	0.0031642249999999997	0.31456100378877994
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0031642249999999997	0.31456100378877994
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0031642249999999997	0.31456100378877994
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0031642249999999997	0.31456100378877994
MARDEN-WALKER SYNDROME	0.0031642249999999997	0.31456100378877994
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0031642249999999997	0.31456100378877994
TYPICAL NEMALINE MYOPATHY	0.0031642249999999997	0.31456100378877994
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0031642249999999997	0.31456100378877994
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.003010559	0.2992848046536974
FLYNN-AIRD SYNDROME	0.003010559	0.2992848046536974
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.003010559	0.2992848046536974
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.003010559	0.2992848046536974
TEMTAMY SYNDROME; TEMTYS	0.003010559	0.2992848046536974
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.003010559	0.2992848046536974
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.003010559	0.2992848046536974
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.003010559	0.2992848046536974
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.003010559	0.2992848046536974
OCULODENTODIGITAL DYSPLASIA	0.003010559	0.2992848046536974
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.003010559	0.2992848046536974
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.003010559	0.2992848046536974
KNOBLOCH SYNDROME	0.003010559	0.2992848046536974
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.003010559	0.2992848046536974
MEHMO SYNDROME; MEHMO	0.003010559	0.2992848046536974
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.003010559	0.2992848046536974
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.003010559	0.2992848046536974
ACROMELIC FRONTONASAL DYSPLASIA	0.003010559	0.2992848046536974
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003010559	0.2992848046536974
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.003010559	0.2992848046536974
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.003010559	0.2992848046536974
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.003010559	0.2992848046536974
GYRATE ATROPHY OF CHOROID AND RETINA	0.003010559	0.2992848046536974
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.003010559	0.2992848046536974
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.003010559	0.2992848046536974
5Q35 MICRODUPLICATION SYNDROME	0.003010559	0.2992848046536974
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.003010559	0.2992848046536974
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.003010559	0.2992848046536974
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.003010559	0.2992848046536974
MUSCLE-EYE-BRAIN DISEASE	0.003010559	0.2992848046536974
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.003010559	0.2992848046536974
DONNAI-BARROW SYNDROME	0.003010559	0.2992848046536974
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0027106189999999996	0.26946725771047847
AICARDI-GOUTIERES SYNDROME 7	0.0027106189999999996	0.26946725771047847
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027106189999999996	0.26946725771047847
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0027106189999999996	0.26946725771047847
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0027106189999999996	0.26946725771047847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0027106189999999996	0.26946725771047847
RETINITIS PIGMENTOSA 59; RP59	0.0027106189999999996	0.26946725771047847
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.0027106189999999996	0.26946725771047847
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0027106189999999996	0.26946725771047847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0027106189999999996	0.26946725771047847
RFT1-CDG	0.0027106189999999996	0.26946725771047847
17Q12 MICRODELETION SYNDROME	0.0027106189999999996	0.26946725771047847
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0027106189999999996	0.26946725771047847
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0027106189999999996	0.26946725771047847
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0027106189999999996	0.26946725771047847
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0027106189999999996	0.26946725771047847
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.0027106189999999996	0.26946725771047847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0027106189999999996	0.26946725771047847
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0027106189999999996	0.26946725771047847
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0027106189999999996	0.26946725771047847
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.0027106189999999996	0.26946725771047847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0027106189999999996	0.26946725771047847
STT3B-CDG	0.0027106189999999996	0.26946725771047847
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0027106189999999996	0.26946725771047847
HELSMOORTEL-VAN DER AA SYNDROME	0.0027106189999999996	0.26946725771047847
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0027106189999999996	0.26946725771047847
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0027106189999999996	0.26946725771047847
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0027106189999999996	0.26946725771047847
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0027106189999999996	0.26946725771047847
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0027106189999999996	0.26946725771047847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0027106189999999996	0.26946725771047847
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0027106189999999996	0.26946725771047847
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0027106189999999996	0.26946725771047847
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0027106189999999996	0.26946725771047847
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0027106189999999996	0.26946725771047847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0027106189999999996	0.26946725771047847
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0027106189999999996	0.26946725771047847
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0027106189999999996	0.26946725771047847
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0027106189999999996	0.26946725771047847
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0027106189999999996	0.26946725771047847
8P11.2 DELETION SYNDROME	0.0027106189999999996	0.26946725771047847
STT3A-CDG	0.0027106189999999996	0.26946725771047847
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0027106189999999996	0.26946725771047847
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0027106189999999996	0.26946725771047847
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0027106189999999996	0.26946725771047847
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0027106189999999996	0.26946725771047847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0027106189999999996	0.26946725771047847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0027106189999999996	0.26946725771047847
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.26946725771047847
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0027106189999999996	0.26946725771047847
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0027106189999999996	0.26946725771047847
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0027106189999999996	0.26946725771047847
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0027106189999999996	0.26946725771047847
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0027106189999999996	0.26946725771047847
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0027106189999999996	0.26946725771047847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0027106189999999996	0.26946725771047847
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0027106189999999996	0.26946725771047847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0027106189999999996	0.26946725771047847
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0027106189999999996	0.26946725771047847
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0027106189999999996	0.26946725771047847
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.0027106189999999996	0.26946725771047847
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0027106189999999996	0.26946725771047847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0027106189999999996	0.26946725771047847
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0027106189999999996	0.26946725771047847
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0027106189999999996	0.26946725771047847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0027106189999999996	0.26946725771047847
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0027106189999999996	0.26946725771047847
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0027106189999999996	0.26946725771047847
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0027106189999999996	0.26946725771047847
19P13.13 MICRODELETION SYNDROME	0.0027106189999999996	0.26946725771047847
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0027106189999999996	0.26946725771047847
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0027106189999999996	0.26946725771047847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0027106189999999996	0.26946725771047847
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0027106189999999996	0.26946725771047847
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.0027106189999999996	0.26946725771047847
SMITH-KINGSMORE SYNDROME; SKS	0.0027106189999999996	0.26946725771047847
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027106189999999996	0.26946725771047847
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.26946725771047847
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.26946725771047847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0027106189999999996	0.26946725771047847
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0027106189999999996	0.26946725771047847
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0027106189999999996	0.26946725771047847
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0027106189999999996	0.26946725771047847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0027106189999999996	0.26946725771047847
COFFIN-SIRIS SYNDROME 2; CSS2	0.0027106189999999996	0.26946725771047847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0027106189999999996	0.26946725771047847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0027106189999999996	0.26946725771047847
COFFIN-SIRIS SYNDROME 5	0.0027106189999999996	0.26946725771047847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0027106189999999996	0.26946725771047847
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0027106189999999996	0.26946725771047847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0027106189999999996	0.26946725771047847
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0027106189999999996	0.26946725771047847
MONOSOMY 9Q22.3	0.0027106189999999996	0.26946725771047847
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0027106189999999996	0.26946725771047847
5Q14.3 MICRODELETION SYNDROME	0.0027106189999999996	0.26946725771047847
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0027106189999999996	0.26946725771047847
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0027106189999999996	0.26946725771047847
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0027106189999999996	0.26946725771047847
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0027106189999999996	0.26946725771047847
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.26946725771047847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0027106189999999996	0.26946725771047847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0027106189999999996	0.26946725771047847
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0027106189999999996	0.26946725771047847
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.00246914	0.24546141848162759
CHAR SYNDROME	0.00246914	0.24546141848162759
GASTROCUTANEOUS SYNDROME	0.00246914	0.24546141848162759
GAPO SYNDROME	0.00246914	0.24546141848162759
USHER SYNDROME TYPE 2	0.00246914	0.24546141848162759
HYPERTRYPTOPHANEMIA; HYPTRP	0.00246914	0.24546141848162759
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00246914	0.24546141848162759
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00246914	0.24546141848162759
VAN BOGAERT-HOZAY SYNDROME	0.00246914	0.24546141848162759
OPTIC ATROPHY 11; OPA11	0.00246914	0.24546141848162759
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00246914	0.24546141848162759
6Q16 MICRODELETION SYNDROME	0.00246914	0.24546141848162759
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00246914	0.24546141848162759
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00246914	0.24546141848162759
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00246914	0.24546141848162759
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00246914	0.24546141848162759
BLUE CONE MONOCHROMACY; BCM	0.00246914	0.24546141848162759
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00246914	0.24546141848162759
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00246914	0.24546141848162759
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00246914	0.24546141848162759
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00246914	0.24546141848162759
OCULOCUTANEOUS ALBINISM	0.00246914	0.24546141848162759
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00246914	0.24546141848162759
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00246914	0.24546141848162759
BIOTINIDASE DEFICIENCY	0.00246914	0.24546141848162759
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00246914	0.24546141848162759
X-LINKED RECESSIVE OCULAR ALBINISM	0.00246914	0.24546141848162759
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00246914	0.24546141848162759
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00246914	0.24546141848162759
16P12.1P12.3 TRIPLICATION SYNDROME	0.00246914	0.24546141848162759
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00246914	0.24546141848162759
MYOPIA, INFANTILE SEVERE	0.00246914	0.24546141848162759
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00246914	0.24546141848162759
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00246914	0.24546141848162759
CHOROIDEREMIA	0.00246914	0.24546141848162759
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00246914	0.24546141848162759
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00246914	0.24546141848162759
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00246914	0.24546141848162759
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00246914	0.24546141848162759
ALPORT SYNDROME, X-LINKED; ATS	0.00246914	0.24546141848162759
BARDET-BIEDL SYNDROME 21; BBS21	0.00246914	0.24546141848162759
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00246914	0.24546141848162759
%310460 MYOPIA 1, X-LINKED; MYP1	0.00246914	0.24546141848162759
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00246914	0.24546141848162759
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00246914	0.24546141848162759
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00246914	0.24546141848162759
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00246914	0.24546141848162759
RETINITIS PIGMENTOSA 75; RP75	0.00246914	0.24546141848162759
ALAND ISLAND EYE DISEASE	0.00246914	0.24546141848162759
ÅLAND ISLANDS EYE DISEASE	0.00246914	0.24546141848162759
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00246914	0.24546141848162759
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00246914	0.24546141848162759
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.00246914	0.24546141848162759
MESOMELIA-SYNOSTOSES SYNDROME	0.00246914	0.24546141848162759
MICROSPHEROPHAKIA WITH HERNIA	0.00246914	0.24546141848162759
MYOPIA 15; MYP15	0.00246914	0.24546141848162759
WEILL-MARCHESANI SYNDROME 3	0.00246914	0.24546141848162759
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00246914	0.24546141848162759
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00246914	0.24546141848162759
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00246914	0.24546141848162759
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00246914	0.24546141848162759
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00246914	0.24546141848162759
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00246914	0.24546141848162759
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00246914	0.24546141848162759
RETINAL CONE DYSTROPHY 3B	0.00246914	0.24546141848162759
RETINITIS PIGMENTOSA 1	0.00246914	0.24546141848162759
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00246914	0.24546141848162759
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00246914	0.24546141848162759
CATARACT-MICROCORNEA SYNDROME	0.00246914	0.24546141848162759
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00246914	0.24546141848162759
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00246914	0.24546141848162759
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00246914	0.24546141848162759
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00246914	0.24546141848162759
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.00246914	0.24546141848162759
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00246914	0.24546141848162759
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00246914	0.24546141848162759
ACROCRANIOFACIAL DYSOSTOSIS	0.00246914	0.24546141848162759
%609259 MYOPIA 10; MYP10	0.00246914	0.24546141848162759
%609258 MYOPIA 9; MYP9	0.00246914	0.24546141848162759
%609257 MYOPIA 8; MYP8	0.00246914	0.24546141848162759
%609256 MYOPIA 7; MYP7	0.00246914	0.24546141848162759
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00246914	0.24546141848162759
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00246914	0.24546141848162759
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00246914	0.24546141848162759
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00246914	0.24546141848162759
MICROCORIA, CONGENITAL	0.00246914	0.24546141848162759
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00246914	0.24546141848162759
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.00246914	0.24546141848162759
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00246914	0.24546141848162759
SVEINSSON CHORIORETINAL ATROPHY	0.00246914	0.24546141848162759
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.00246914	0.24546141848162759
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00246914	0.24546141848162759
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00246914	0.24546141848162759
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00246914	0.24546141848162759
ALAGILLE SYNDROME 1; ALGS1	0.00246914	0.24546141848162759
PROTEUS-LIKE SYNDROME	0.00246914	0.24546141848162759
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00246914	0.24546141848162759
NOONAN SYNDROME 6; NS6	0.00246914	0.24546141848162759
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00246914	0.24546141848162759
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00246914	0.24546141848162759
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00246914	0.24546141848162759
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.00246914	0.24546141848162759
HYPEREKPLEXIA 2; HKPX2	0.00246914	0.24546141848162759
POLYDACTYLY-MYOPIA SYNDROME	0.00246914	0.24546141848162759
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00246914	0.24546141848162759
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.00246914	0.24546141848162759
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00246914	0.24546141848162759
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00246914	0.24546141848162759
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00246914	0.24546141848162759
GASTROCUTANEOUS SYNDROME	0.00246914	0.24546141848162759
GLAUCOMA 1, OPEN ANGLE, A	0.00246914	0.24546141848162759
GLAUCOMA, PRIMARY OPEN ANGLE	0.00246914	0.24546141848162759
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00246914	0.24546141848162759
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00246914	0.24546141848162759
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00246914	0.24546141848162759
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00246914	0.24546141848162759
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00246914	0.24546141848162759
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00246914	0.24546141848162759
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00246914	0.24546141848162759
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00246914	0.24546141848162759
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00246914	0.24546141848162759
STICKLER SYNDROME TYPE 2	0.00246914	0.24546141848162759
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00246914	0.24546141848162759
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00246914	0.24546141848162759
CRANIOECTODERMAL DYSPLASIA 1	0.00246914	0.24546141848162759
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00246914	0.24546141848162759
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00246914	0.24546141848162759
USHER SYNDROME	0.00246914	0.24546141848162759
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00246914	0.24546141848162759
CRANIOECTODERMAL DYSPLASIA	0.00246914	0.24546141848162759
XP22.3 MICRODELETION SYNDROME	0.00246914	0.24546141848162759
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00246914	0.24546141848162759
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00246914	0.24546141848162759
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.00246914	0.24546141848162759
FRONTOOCULAR SYNDROME	0.00246914	0.24546141848162759
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00246914	0.24546141848162759
SPONDYLO-OCULAR SYNDROME	0.00246914	0.24546141848162759
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00246914	0.24546141848162759
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00246914	0.24546141848162759
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00246914	0.24546141848162759
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.00246914	0.24546141848162759
BARDET-BIEDL SYNDROME 1; BBS1	0.00246914	0.24546141848162759
STICKLER SYNDROME TYPE 1	0.00246914	0.24546141848162759
RENAL COLOBOMA SYNDROME	0.00246914	0.24546141848162759
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00246914	0.24546141848162759
XYLT1-CDG	0.00246914	0.24546141848162759
ABLEPHARON MACROSTOMIA SYNDROME	0.00246914	0.24546141848162759
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00246914	0.24546141848162759
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00246914	0.24546141848162759
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00246914	0.24546141848162759
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.00246914	0.24546141848162759
TRIGEMINAL NEURALGIA	0.0021691999999999996	0.21564387153840872
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.21564387153840872
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.21564387153840872
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0021691999999999996	0.21564387153840872
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.21564387153840872
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0021691999999999996	0.21564387153840872
KRABBE DISEASE	0.0021691999999999996	0.21564387153840872
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.0021691999999999996	0.21564387153840872
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0021691999999999996	0.21564387153840872
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021691999999999996	0.21564387153840872
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0021691999999999996	0.21564387153840872
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0021691999999999996	0.21564387153840872
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.21564387153840872
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0021691999999999996	0.21564387153840872
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0021691999999999996	0.21564387153840872
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0021691999999999996	0.21564387153840872
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0021691999999999996	0.21564387153840872
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.0021691999999999996	0.21564387153840872
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.21564387153840872
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0021691999999999996	0.21564387153840872
LOCKED-IN SYNDROME	0.0021691999999999996	0.21564387153840872
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0021691999999999996	0.21564387153840872
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.21564387153840872
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.21564387153840872
BILATERAL POLYMICROGYRIA	0.0021691999999999996	0.21564387153840872
2Q32Q33 MICRODELETION SYNDROME	0.0021691999999999996	0.21564387153840872
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0021691999999999996	0.21564387153840872
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0021691999999999996	0.21564387153840872
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0021691999999999996	0.21564387153840872
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0021691999999999996	0.21564387153840872
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021691999999999996	0.21564387153840872
COMBINED SAPOSIN DEFICIENCY	0.0021691999999999996	0.21564387153840872
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.0021691999999999996	0.21564387153840872
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.0021691999999999996	0.21564387153840872
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.21564387153840872
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.21564387153840872
BETA-THALASSEMIA MAJOR	0.0021691999999999996	0.21564387153840872
DESMOSTEROLOSIS	0.0021691999999999996	0.21564387153840872
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0021691999999999996	0.21564387153840872
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.0021691999999999996	0.21564387153840872
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0021691999999999996	0.21564387153840872
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.21564387153840872
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.0021691999999999996	0.21564387153840872
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0021691999999999996	0.21564387153840872
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0021691999999999996	0.21564387153840872
PEHO SYNDROME	0.0021691999999999996	0.21564387153840872
ISOLATED COMPLEX I DEFICIENCY	0.0021691999999999996	0.21564387153840872
LYSINURIC PROTEIN INTOLERANCE	0.0021691999999999996	0.21564387153840872
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0021691999999999996	0.21564387153840872
SALT-AND-PEPPER SYNDROME	0.0021691999999999996	0.21564387153840872
COG4-CDG	0.0021691999999999996	0.21564387153840872
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0021691999999999996	0.21564387153840872
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.21564387153840872
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.21564387153840872
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.0021691999999999996	0.21564387153840872
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.21564387153840872
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0021691999999999996	0.21564387153840872
EAR-PATELLA-SHORT STATURE SYNDROME	0.0021691999999999996	0.21564387153840872
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.21564387153840872
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0021691999999999996	0.21564387153840872
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0021691999999999996	0.21564387153840872
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0021691999999999996	0.21564387153840872
OROFACIODIGITAL SYNDROME TYPE 4	0.0021691999999999996	0.21564387153840872
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.21564387153840872
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0021691999999999996	0.21564387153840872
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.21564387153840872
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.21564387153840872
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0021691999999999996	0.21564387153840872
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.21564387153840872
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.21564387153840872
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0021691999999999996	0.21564387153840872
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.0021691999999999996	0.21564387153840872
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.0021691999999999996	0.21564387153840872
AMISH LETHAL MICROCEPHALY	0.0021691999999999996	0.21564387153840872
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.21564387153840872
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0021691999999999996	0.21564387153840872
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.21564387153840872
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0021691999999999996	0.21564387153840872
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.21564387153840872
48,XYYY SYNDROME	0.0021691999999999996	0.21564387153840872
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.0021691999999999996	0.21564387153840872
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.21564387153840872
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0021691999999999996	0.21564387153840872
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0021691999999999996	0.21564387153840872
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0021691999999999996	0.21564387153840872
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0021691999999999996	0.21564387153840872
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.0021691999999999996	0.21564387153840872
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.21564387153840872
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0021691999999999996	0.21564387153840872
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.0021691999999999996	0.21564387153840872
X SMALL RINGS	0.0021691999999999996	0.21564387153840872
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.21564387153840872
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.21564387153840872
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.21564387153840872
CHOANAL ATRESIA	0.0021691999999999996	0.21564387153840872
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.21564387153840872
LARYNGOTRACHEAL ANGIOMA	0.0021691999999999996	0.21564387153840872
CRISS-CROSS HEART	0.0021691999999999996	0.21564387153840872
CHIARI MALFORMATION TYPE II	0.0021691999999999996	0.21564387153840872
PEHO-LIKE SYNDROME; PEHOL	0.0021691999999999996	0.21564387153840872
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0021691999999999996	0.21564387153840872
CLASSIC GALACTOSEMIA	0.0021691999999999996	0.21564387153840872
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.21564387153840872
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0021691999999999996	0.21564387153840872
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.21564387153840872
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.21564387153840872
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0021691999999999996	0.21564387153840872
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.21564387153840872
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.21564387153840872
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.21564387153840872
AURICULOCONDYLAR SYNDROME	0.0021691999999999996	0.21564387153840872
SPINOCEREBELLAR ATAXIA TYPE 7	0.0021691999999999996	0.21564387153840872
GALACTOSE EPIMERASE DEFICIENCY	0.0021691999999999996	0.21564387153840872
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0021691999999999996	0.21564387153840872
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.001536444	0.15274051842244096
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.001536444	0.15274051842244096
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.001536444	0.15274051842244096
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.001536444	0.15274051842244096
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.001536444	0.15274051842244096
2Q31.1 MICRODELETION SYNDROME	0.001536444	0.15274051842244096
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001536444	0.15274051842244096
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.001536444	0.15274051842244096
TETRASOMY 18P	0.001536444	0.15274051842244096
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001536444	0.15274051842244096
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001536444	0.15274051842244096
SIALIDOSIS TYPE 1	0.001536444	0.15274051842244096
ISOLATED SPINA BIFIDA	0.001536444	0.15274051842244096
KLEEFSTRA SYNDROME 2; KLEFS2	0.001536444	0.15274051842244096
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001536444	0.15274051842244096
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.001536444	0.15274051842244096
MICRO SYNDROME	0.001536444	0.15274051842244096
CHROMOSOME 18Q DELETION SYNDROME	0.001536444	0.15274051842244096
1Q21.1 MICRODELETION SYNDROME	0.001536444	0.15274051842244096
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001536444	0.15274051842244096
XP22.13P22.2 DUPLICATION SYNDROME	0.001536444	0.15274051842244096
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001536444	0.15274051842244096
NEUROFIBROMATOSIS, TYPE I	0.001536444	0.15274051842244096
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.001536444	0.15274051842244096
MENTAL RETARDATION, X-LINKED 82	0.001536444	0.15274051842244096
KOOLEN-DE VRIES SYNDROME	0.001536444	0.15274051842244096
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.001536444	0.15274051842244096
SECKEL SYNDROME 1; SCKL1	0.001536444	0.15274051842244096
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001536444	0.15274051842244096
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001536444	0.15274051842244096
SIMPSON-GOLABI-BEHMEL SYNDROME	0.001536444	0.15274051842244096
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001536444	0.15274051842244096
ASPARTYLGLUCOSAMINURIA; AGU	0.001536444	0.15274051842244096
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001536444	0.15274051842244096
ASPARTYLGLUCOSAMINURIA	0.001536444	0.15274051842244096
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.001536444	0.15274051842244096
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001536444	0.15274051842244096
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001536444	0.15274051842244096
COFFIN-SIRIS SYNDROME	0.001536444	0.15274051842244096
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.001536444	0.15274051842244096
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001536444	0.15274051842244096
DIGEORGE SYNDROME; DGS	0.001536444	0.15274051842244096
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001536444	0.15274051842244096
15Q24 MICRODELETION SYNDROME	0.001536444	0.15274051842244096
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001536444	0.15274051842244096
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001536444	0.15274051842244096
RECOMBINANT 8 SYNDROME	0.001536444	0.15274051842244096
15Q14 MICRODELETION SYNDROME	0.001536444	0.15274051842244096
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.001536444	0.15274051842244096
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001536444	0.15274051842244096
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.001536444	0.15274051842244096
TRISOMY 13	0.001536444	0.15274051842244096
WOLF-HIRSCHHORN SYNDROME	0.001536444	0.15274051842244096
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001536444	0.15274051842244096
CONO-SPONDYLAR DYSPLASIA	0.001536444	0.15274051842244096
8P INVERTED DUPLICATION/DELETION SYNDROME	0.001536444	0.15274051842244096
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.001536444	0.15274051842244096
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001536444	0.15274051842244096
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001536444	0.15274051842244096
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.001536444	0.15274051842244096
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.001536444	0.15274051842244096
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001536444	0.15274051842244096
C SYNDROME	0.001536444	0.15274051842244096
LINEAR VERRUCOUS NEVUS SYNDROME	0.001536444	0.15274051842244096
MONOSOMY 9P	0.001536444	0.15274051842244096
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.001536444	0.15274051842244096
MARDEN-WALKER SYNDROME	0.001536444	0.15274051842244096
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001536444	0.15274051842244096
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001536444	0.15274051842244096
MENTAL RETARDATION, X-LINKED 102	0.001536444	0.15274051842244096
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001536444	0.15274051842244096
FAMILIAL MULTIPLE NEVI FLAMMEI	0.001536444	0.15274051842244096
HALL-RIGGS SYNDROME	0.001536444	0.15274051842244096
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.001536444	0.15274051842244096
RENPENNING SYNDROME 1; RENS1	0.001536444	0.15274051842244096
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001536444	0.15274051842244096
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.001536444	0.15274051842244096
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001536444	0.15274051842244096
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001536444	0.15274051842244096
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001536444	0.15274051842244096
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001536444	0.15274051842244096
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.001536444	0.15274051842244096
FRAGILE X MENTAL RETARDATION SYNDROME	0.001536444	0.15274051842244096
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001536444	0.15274051842244096
9Q21.13 MICRODELETION SYNDROME	0.001536444	0.15274051842244096
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.001536444	0.15274051842244096
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.001536444	0.15274051842244096
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.001536444	0.15274051842244096
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001536444	0.15274051842244096
NEVUS COMEDONICUS SYNDROME	0.001536444	0.15274051842244096
WEAVER SYNDROME	0.001536444	0.15274051842244096
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001536444	0.15274051842244096
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001536444	0.15274051842244096
RUVALCABA SYNDROME	0.001536444	0.15274051842244096
RAMON SYNDROME	0.001536444	0.15274051842244096
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.001536444	0.15274051842244096
COFFIN-LOWRY SYNDROME; CLS	0.001536444	0.15274051842244096
PETTIGREW SYNDROME	0.001536444	0.15274051842244096
SHASHI-PENA SYNDROME; SHAPNS	0.001536444	0.15274051842244096
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.001536444	0.15274051842244096
WITTEVEEN-KOLK SYNDROME	0.001536444	0.15274051842244096
HARROD SYNDROME	0.001536444	0.15274051842244096
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001536444	0.15274051842244096
CENTRONUCLEAR MYOPATHY	0.001536444	0.15274051842244096
COFFIN-LOWRY SYNDROME	0.001536444	0.15274051842244096
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.001536444	0.15274051842244096
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.001536444	0.15274051842244096
RETT SYNDROME	0.001536444	0.15274051842244096
JOUBERT SYNDROME	0.001536444	0.15274051842244096
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.001536444	0.15274051842244096
INTELLECTUAL DISABILITY, WOLFF TYPE	0.001536444	0.15274051842244096
4Q21 MICRODELETION SYNDROME	0.001536444	0.15274051842244096
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.001536444	0.15274051842244096
6Q TERMINAL DELETION SYNDROME	0.001536444	0.15274051842244096
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001536444	0.15274051842244096
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.001536444	0.15274051842244096
MICROPHTHALMIA, LENZ TYPE	0.001536444	0.15274051842244096
X-LINKED CENTRONUCLEAR MYOPATHY	0.001536444	0.15274051842244096
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001536444	0.15274051842244096
ATKIN-FLAITZ SYNDROME	0.001536444	0.15274051842244096
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001536444	0.15274051842244096
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001536444	0.15274051842244096
CLARK-BARAITSER SYNDROME	0.001536444	0.15274051842244096
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1	0.000995025	0.0989171322503712
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.000995025	0.0989171322503712
SPRENGEL DEFORMITY	0.000995025	0.0989171322503712
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.000995025	0.0989171322503712
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.000995025	0.0989171322503712
BASAL CELL NEVUS SYNDROME	0.000995025	0.0989171322503712
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.000995025	0.0989171322503712
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.000995025	0.0989171322503712
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000995025	0.0989171322503712
RUVALCABA SYNDROME	0.000995025	0.0989171322503712
TIBIAL TORSION, BILATERAL MEDIAL	0.000995025	0.0989171322503712
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.000995025	0.0989171322503712
MOSAIC TRISOMY 9	0.000995025	0.0989171322503712
SHPRINTZEN OMPHALOCELE SYNDROME	0.000995025	0.0989171322503712
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.000995025	0.0989171322503712
FRIEDREICH ATAXIA	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.000995025	0.0989171322503712
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.000995025	0.0989171322503712
12Q14 MICRODELETION SYNDROME	0.000995025	0.0989171322503712
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.000995025	0.0989171322503712
SYRINGOMYELIA, ISOLATED	0.000995025	0.0989171322503712
THORACOLARYNGOPELVIC DYSPLASIA	0.000995025	0.0989171322503712
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.000995025	0.0989171322503712
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.000995025	0.0989171322503712
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.000995025	0.0989171322503712
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.000995025	0.0989171322503712
NEMALINE MYOPATHY 1; NEM1	0.000995025	0.0989171322503712
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.000995025	0.0989171322503712
MADELUNG DEFORMITY	0.000995025	0.0989171322503712
OSTEOGENESIS IMPERFECTA, TYPE X	0.000995025	0.0989171322503712
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.000995025	0.0989171322503712
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.000995025	0.0989171322503712
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000995025	0.0989171322503712
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.000995025	0.0989171322503712
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.000995025	0.0989171322503712
9P13 MICRODELETION SYNDROME	0.000995025	0.0989171322503712
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.000995025	0.0989171322503712
MYOPATHY, DISTAL, 1; MPD1	0.000995025	0.0989171322503712
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.000995025	0.0989171322503712
SPASTIC PARAPLEGIA TYPE 7	0.000995025	0.0989171322503712
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000995025	0.0989171322503712
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.000995025	0.0989171322503712
BETA-UREIDOPROPIONASE DEFICIENCY	0.000995025	0.0989171322503712
DUCHENNE MUSCULAR DYSTROPHY	0.000995025	0.0989171322503712
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.000995025	0.0989171322503712
LERI-WEILL DYSCHONDROSTEOSIS	0.000995025	0.0989171322503712
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.000995025	0.0989171322503712
NEMALINE MYOPATHY 3; NEM3	0.000995025	0.0989171322503712
NAIL-PATELLA SYNDROME	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.000995025	0.0989171322503712
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.000995025	0.0989171322503712
OROFACIODIGITAL SYNDROME V; OFD5	0.000995025	0.0989171322503712
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.000995025	0.0989171322503712
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.000995025	0.0989171322503712
CENANI-LENZ SYNDROME	0.000995025	0.0989171322503712
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.000995025	0.0989171322503712
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.000995025	0.0989171322503712
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.000995025	0.0989171322503712
DYSTONIA, DOPA-RESPONSIVE; DRD	0.000995025	0.0989171322503712
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000995025	0.0989171322503712
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.000995025	0.0989171322503712
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.000995025	0.0989171322503712
CLASSIC MULTIMINICORE MYOPATHY	0.000995025	0.0989171322503712
METATROPIC DYSPLASIA	0.000995025	0.0989171322503712
IVIC SYNDROME	0.000995025	0.0989171322503712
SALIH MYOPATHY; SALMY	0.000995025	0.0989171322503712
JOUBERT SYNDROME 7	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.000995025	0.0989171322503712
PSEUDOACHONDROPLASIA	0.000995025	0.0989171322503712
ACRO-RENAL-MANDIBULAR SYNDROME	0.000995025	0.0989171322503712
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000995025	0.0989171322503712
ATAXIA WITH VITAMIN E DEFICIENCY	0.000995025	0.0989171322503712
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000995025	0.0989171322503712
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.000995025	0.0989171322503712
WEAVER SYNDROME	0.000995025	0.0989171322503712
CLEIDOCRANIAL DYSPLASIA; CCD	0.000995025	0.0989171322503712
SHOX-RELATED SHORT STATURE	0.000995025	0.0989171322503712
MOSAIC TRISOMY 8	0.000995025	0.0989171322503712
FETAL AKINESIA DEFORMATION SEQUENCE	0.000995025	0.0989171322503712
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.000995025	0.0989171322503712
NOONAN SYNDROME 4; NS4	0.000995025	0.0989171322503712
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.000995025	0.0989171322503712
XFE PROGEROID SYNDROME; XFEPS	0.000995025	0.0989171322503712
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.000995025	0.0989171322503712
49,XYYYY SYNDROME	0.000995025	0.0989171322503712
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.000995025	0.0989171322503712
SILLENCE SYNDROME	0.000995025	0.0989171322503712
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000995025	0.0989171322503712
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.000995025	0.0989171322503712
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000995025	0.0989171322503712
POSTERIOR COLUMN ATAXIA	0.000995025	0.0989171322503712
SPONDYLOCAMPTODACTYLY SYNDROME	0.000995025	0.0989171322503712
WEISMANN-NETTER SYNDROME	0.000995025	0.0989171322503712
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.000995025	0.0989171322503712
DISTAL MONOSOMY 6P	0.000995025	0.0989171322503712
SPONDYLOCOSTAL DYSOSTOSIS 5	0.000995025	0.0989171322503712
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.000995025	0.0989171322503712
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.000995025	0.0989171322503712
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.000995025	0.0989171322503712
PYLE DISEASE; PYL	0.000995025	0.0989171322503712
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.000995025	0.0989171322503712
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.000995025	0.0989171322503712
PSEUDOACHONDROPLASIA	0.000995025	0.0989171322503712
ATELOSTEOGENESIS, TYPE II	0.000995025	0.0989171322503712
OPSISMODYSPLASIA; OPSMD	0.000995025	0.0989171322503712
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.000995025	0.0989171322503712
TERMINAL TRANSVERSE LIMB DEFECT	0.000995025	0.0989171322503712
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.000995025	0.0989171322503712
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000995025	0.0989171322503712
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.000995025	0.0989171322503712
PSEUDODIASTROPHIC DYSPLASIA	0.000995025	0.0989171322503712
PYCNODYSOSTOSIS	0.000995025	0.0989171322503712
LARSEN SYNDROME	0.000995025	0.0989171322503712
CRANIOLENTICULOSUTURAL DYSPLASIA	0.000995025	0.0989171322503712
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.000995025	0.0989171322503712
LEBER OPTIC ATROPHY AND DYSTONIA	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.000995025	0.0989171322503712
SPONDYLOCAMPTODACTYLY	0.000995025	0.0989171322503712
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.000995025	0.0989171322503712
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.000995025	0.0989171322503712
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.000995025	0.0989171322503712
MARINESCO-SJOGREN SYNDROME; MSS	0.000995025	0.0989171322503712
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000995025	0.0989171322503712
METAPHYSEAL ACROSCYPHODYSPLASIA	0.000995025	0.0989171322503712
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.000995025	0.0989171322503712
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.000995025	0.0989171322503712
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.000995025	0.0989171322503712
MUCOLIPIDOSIS III ALPHA/BETA	0.000995025	0.0989171322503712
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000995025	0.0989171322503712
MORQUIO SYNDROME A	0.000995025	0.0989171322503712
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.000995025	0.0989171322503712
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000995025	0.0989171322503712
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.000995025	0.0989171322503712
FRONTOMETAPHYSEAL DYSPLASIA	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.000995025	0.0989171322503712
FOCAL DERMAL HYPOPLASIA; FDH	0.000995025	0.0989171322503712
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.000995025	0.0989171322503712
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000995025	0.0989171322503712
HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	0.000995025	0.0989171322503712
ACROCAPITOFEMORAL DYSPLASIA	0.000995025	0.0989171322503712
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000995025	0.0989171322503712
DIASTROPHIC DWARFISM	0.000995025	0.0989171322503712
OGDEN SYNDROME; OGDNS	0.000995025	0.0989171322503712
MULTIMINICORE MYOPATHY	0.000995025	0.0989171322503712
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.000995025	0.0989171322503712
ALLAN-HERNDON-DUDLEY SYNDROME	0.000995025	0.0989171322503712
LAING EARLY-ONSET DISTAL MYOPATHY	0.000995025	0.0989171322503712
ALLAN-HERNDON-DUDLEY SYNDROME	0.000995025	0.0989171322503712
MUCOPOLYSACCHARIDOSIS TYPE 7	0.000995025	0.0989171322503712
MUCOPOLYSACCHARIDOSIS TYPE 4	0.000995025	0.0989171322503712
MUCOPOLYSACCHARIDOSIS TYPE 1	0.000995025	0.0989171322503712
WEILL-MARCHESANI SYNDROME 1; WMS1	0.000995025	0.0989171322503712
BECKER NEVUS SYNDROME	0.000995025	0.0989171322503712
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000995025	0.0989171322503712
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000995025	0.0989171322503712
ROTHMUND-THOMSON SYNDROME	0.000995025	0.0989171322503712
AARSKOG-SCOTT SYNDROME	0.000995025	0.0989171322503712
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.000995025	0.0989171322503712
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000995025	0.0989171322503712
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.000995025	0.0989171322503712
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.000995025	0.0989171322503712
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000995025	0.0989171322503712
NOONAN SYNDROME	0.000995025	0.0989171322503712
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.000995025	0.0989171322503712
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.000995025	0.0989171322503712
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.000995025	0.0989171322503712
BRADDOCK SYNDROME	0.000995025	0.0989171322503712
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.000995025	0.0989171322503712
SECKEL SYNDROME	0.000995025	0.0989171322503712
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.000995025	0.0989171322503712
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.000995025	0.0989171322503712
DUANE-RADIAL RAY SYNDROME; DRRS	0.000995025	0.0989171322503712
GOLDENHAR SYNDROME	0.000995025	0.0989171322503712
GORDON SYNDROME	0.000995025	0.0989171322503712
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.000995025	0.0989171322503712
GORLIN SYNDROME	0.000995025	0.0989171322503712
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.000995025	0.0989171322503712
FRONTORHINY	0.000995025	0.0989171322503712
HOLT-ORAM SYNDROME	0.000995025	0.0989171322503712
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.000995025	0.0989171322503712
WEILL-MARCHESANI SYNDROME 2; WMS2	0.000995025	0.0989171322503712
OCULOAURICULOFRONTONASAL SYNDROME	0.000995025	0.0989171322503712
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.000995025	0.0989171322503712
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.000995025	0.0989171322503712
OTOPALATODIGITAL SYNDROME TYPE 2	0.000995025	0.0989171322503712
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.000995025	0.0989171322503712
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.000995025	0.0989171322503712
AASE-SMITH SYNDROME	0.000995025	0.0989171322503712
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.000995025	0.0989171322503712
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000995025	0.0989171322503712
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.000995025	0.0989171322503712
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.000995025	0.0989171322503712
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.000995025	0.0989171322503712
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000995025	0.0989171322503712
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.000995025	0.0989171322503712
BRACHYDACTYLY TYPE A1	0.000995025	0.0989171322503712
SPONASTRIME DYSPLASIA	0.000995025	0.0989171322503712
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.000995025	0.0989171322503712
ULNAR HEMIMELIA	0.000995025	0.0989171322503712
CZECH DYSPLASIA, METATARSAL TYPE	0.000995025	0.0989171322503712
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.000995025	0.0989171322503712
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.000995025	0.0989171322503712
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.000995025	0.0989171322503712
BRACHYOLMIA, MAROTEAUX TYPE	0.000995025	0.0989171322503712
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.000995025	0.0989171322503712
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.000995025	0.0989171322503712
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.000995025	0.0989171322503712
3P25.3 MICRODELETION SYNDROME	0.000995025	0.0989171322503712
HYPOPHOSPHATEMIC RICKETS	0.000995025	0.0989171322503712
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.000995025	0.0989171322503712
BRESEK SYNDROME	0.000995025	0.0989171322503712
231970 GLUTEAL MUSCLES, ABSENCE OF	0.000995025	0.0989171322503712
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.000995025	0.0989171322503712
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000995025	0.0989171322503712
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000995025	0.0989171322503712
RIGID SPINE MUSCULAR DYSTROPHY 1	0.000995025	0.0989171322503712
HEMIHYPERPLASIA, ISOLATED	0.000995025	0.0989171322503712
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.000995025	0.0989171322503712
PSEUDODIASTROPHIC DYSPLASIA	0.000995025	0.0989171322503712
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.000995025	0.0989171322503712
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.000995025	0.0989171322503712
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.000995025	0.0989171322503712
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.000995025	0.0989171322503712
FRIED SYNDROME	0.000995025	0.0989171322503712
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.000995025	0.0989171322503712
HURLER-SCHEIE SYNDROME	0.000995025	0.0989171322503712
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.000995025	0.0989171322503712
WAARDENBURG SYNDROME TYPE 1	0.000995025	0.0989171322503712
WAGR SYNDROME	0.000995025	0.0989171322503712
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.000995025	0.0989171322503712
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.000995025	0.0989171322503712
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.000995025	0.0989171322503712
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000995025	0.0989171322503712
HYPOCHONDROPLASIA	0.000995025	0.0989171322503712
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.000995025	0.0989171322503712
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.000995025	0.0989171322503712
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.000995025	0.0989171322503712
FACIOCARDIORENAL SYNDROME	0.000995025	0.0989171322503712
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.000995025	0.0989171322503712
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.000995025	0.0989171322503712
MARINESCO-SJÖGREN SYNDROME	0.000995025	0.0989171322503712
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.000995025	0.0989171322503712
FRYNS-SMEETS-THIRY SYNDROME	0.000995025	0.0989171322503712
OSTEOMESOPYKNOSIS	0.000995025	0.0989171322503712
STEEL SYNDROME; STLS	0.000995025	0.0989171322503712
FRANK-TER HAAR SYNDROME	0.000995025	0.0989171322503712
TRISOMY 9P	0.000995025	0.0989171322503712
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.000995025	0.0989171322503712
LATERAL MENINGOCELE SYNDROME	0.000995025	0.0989171322503712
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.000995025	0.0989171322503712
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.000995025	0.0989171322503712
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000995025	0.0989171322503712
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000995025	0.0989171322503712
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.000995025	0.0989171322503712
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.000995025	0.0989171322503712
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000995025	0.0989171322503712
CATEL-MANZKE SYNDROME	0.000995025	0.0989171322503712
CEREBROFACIOTHORACIC DYSPLASIA	0.000995025	0.0989171322503712
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.000995025	0.0989171322503712
ISOLATED KLIPPEL-FEIL SYNDROME	0.000995025	0.0989171322503712
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.000995025	0.0989171322503712
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.000995025	0.0989171322503712
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.000995025	0.0989171322503712
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.000995025	0.0989171322503712
TRISOMY 5P	0.000995025	0.0989171322503712
TRISOMY 4P	0.000995025	0.0989171322503712
ALAZAMI SYNDROME; ALAZS	0.000995025	0.0989171322503712
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.000995025	0.0989171322503712
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000995025	0.0989171322503712
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.000995025	0.0989171322503712
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000995025	0.0989171322503712
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000995025	0.0989171322503712
ENG-STROM SYNDROME	0.000995025	0.0989171322503712
AYMÉ-GRIPP SYNDROME	0.000995025	0.0989171322503712
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.000995025	0.0989171322503712
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.000995025	0.0989171322503712
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.0989171322503712
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.000995025	0.0989171322503712
CAFFEY DISEASE	0.000995025	0.0989171322503712
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000995025	0.0989171322503712
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.000995025	0.0989171322503712
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.000995025	0.0989171322503712
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.000995025	0.0989171322503712
CAMURATI-ENGELMANN DISEASE	0.000995025	0.0989171322503712
FETAL TRIMETHADIONE SYNDROME	0.000995025	0.0989171322503712
PENTALOGY OF CANTRELL	0.000995025	0.0989171322503712
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000995025	0.0989171322503712
CAREY-FINEMAN-ZITER SYNDROME	0.000995025	0.0989171322503712
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000995025	0.0989171322503712
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.000995025	0.0989171322503712
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.000995025	0.0989171322503712
FRONTOMETAPHYSEAL DYSPLASIA	0.000995025	0.0989171322503712
MYOPATHY, SCAPULOHUMEROPERONEAL	0.000995025	0.0989171322503712
OGDEN SYNDROME	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.000995025	0.0989171322503712
CRANIOSYNOSTOSIS 6; CRS6	0.000995025	0.0989171322503712
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.000995025	0.0989171322503712
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.000995025	0.0989171322503712
NEU-LAXOVA SYNDROME	0.000995025	0.0989171322503712
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000995025	0.0989171322503712
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000995025	0.0989171322503712
OSTEOGLOSPHONIC DYSPLASIA	0.000995025	0.0989171322503712
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000995025	0.0989171322503712
METATROPIC DYSPLASIA	0.000995025	0.0989171322503712
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000995025	0.0989171322503712
CRANIOFRONTONASAL DYSPLASIA	0.000995025	0.0989171322503712
MYOCLONIC-ATONIC EPILEPSY	0.000995025	0.0989171322503712
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.000995025	0.0989171322503712
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000995025	0.0989171322503712
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.000995025	0.0989171322503712
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.000995025	0.0989171322503712
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.000995025	0.0989171322503712
3M SYNDROME	0.000995025	0.0989171322503712
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.000995025	0.0989171322503712
TRISOMY 20P	0.000995025	0.0989171322503712
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.000995025	0.0989171322503712
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.000995025	0.0989171322503712
ARNOLD-CHIARI MALFORMATION TYPE I	0.000995025	0.0989171322503712
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.000995025	0.0989171322503712
COOPER-JABS SYNDROME	0.000995025	0.0989171322503712
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.000995025	0.0989171322503712
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.000995025	0.0989171322503712
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.000995025	0.0989171322503712
DIPHALLIA	0.000995025	0.0989171322503712
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.000995025	0.0989171322503712
45,X/46,XY MIXED GONADAL DYSGENESIS	0.000995025	0.0989171322503712
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.000995025	0.0989171322503712
DESBUQUOIS SYNDROME	0.000995025	0.0989171322503712
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000995025	0.0989171322503712
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.000995025	0.0989171322503712
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.0989171322503712
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.000995025	0.0989171322503712
TRISOMY 17P	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000995025	0.0989171322503712
DYSOSTOSIS, STANESCU TYPE	0.000995025	0.0989171322503712
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.000995025	0.0989171322503712
CODAS SYNDROME	0.000995025	0.0989171322503712
OCULOFACIOCARDIODENTAL SYNDROME	0.000995025	0.0989171322503712
SYMBRACHYDACTYLY OF HANDS AND FEET	0.000995025	0.0989171322503712
JUBERG-HAYWARD SYNDROME	0.000995025	0.0989171322503712
IVIC SYNDROME	0.000995025	0.0989171322503712
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000995025	0.0989171322503712
TOWNES-BROCKS SYNDROME 2; TBS2	0.000995025	0.0989171322503712
1Q44 MICRODELETION SYNDROME	0.000995025	0.0989171322503712
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.000995025	0.0989171322503712
3MC SYNDROME	0.000995025	0.0989171322503712
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.000995025	0.0989171322503712
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.000995025	0.0989171322503712
CAUDAL REGRESSION SEQUENCE	0.000995025	0.0989171322503712
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000995025	0.0989171322503712
NON-DISTAL TRISOMY 10Q	0.000995025	0.0989171322503712
OLIVER SYNDROME	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.000995025	0.0989171322503712
OROFACIODIGITAL SYNDROME TYPE 5	0.000995025	0.0989171322503712
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.000995025	0.0989171322503712
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.000995025	0.0989171322503712
ACROGERIA	0.000995025	0.0989171322503712
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.0989171322503712
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.000995025	0.0989171322503712
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.000995025	0.0989171322503712
NEU-LAXOVA SYNDROME 2; NLS2	0.000995025	0.0989171322503712
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.000995025	0.0989171322503712
ISOLATED HEMIHYPERPLASIA	0.000995025	0.0989171322503712
KUSKOKWIM SYNDROME	0.000995025	0.0989171322503712
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.000995025	0.0989171322503712
LERI PLEONOSTEOSIS	0.000995025	0.0989171322503712
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.000995025	0.0989171322503712
MELNICK-NEEDLES SYNDROME	0.000995025	0.0989171322503712
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.000995025	0.0989171322503712
ACRODYSPLASIA SCOLIOSIS	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.000995025	0.0989171322503712
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.000995025	0.0989171322503712
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.000995025	0.0989171322503712
AREDYLD SYNDROME	0.000995025	0.0989171322503712
CEREBELLOFACIODENTAL SYNDROME	0.000995025	0.0989171322503712
ODONTOCHONDRODYSPLASIA	0.000995025	0.0989171322503712
SPINOCEREBELLAR ATAXIA TYPE 25	0.000995025	0.0989171322503712
HIP DYSPLASIA, BEUKES TYPE	0.000995025	0.0989171322503712
DIASTEMATOMYELIA	0.000995025	0.0989171322503712
SHELDON-HALL SYNDROME	0.000995025	0.0989171322503712
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.000995025	0.0989171322503712
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.000995025	0.0989171322503712
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.000995025	0.0989171322503712
MCDONOUGH SYNDROME	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.000995025	0.0989171322503712
MYASTHENIC SYNDROME, CONGENITAL, 13	0.000995025	0.0989171322503712
MAXILLONASAL DYSPLASIA	0.000995025	0.0989171322503712
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.000995025	0.0989171322503712
METAPHYSEAL ACROSCYPHODYSPLASIA	0.000995025	0.0989171322503712
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.000995025	0.0989171322503712
FREEMAN-SHELDON SYNDROME	0.000995025	0.0989171322503712
BALLER-GEROLD SYNDROME	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.000995025	0.0989171322503712
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000995025	0.0989171322503712
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.000995025	0.0989171322503712
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.000995025	0.0989171322503712
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.000995025	0.0989171322503712
GENITOPALATOCARDIAC SYNDROME	0.000995025	0.0989171322503712
MICROTRIPLICATION 11Q24.1	0.000995025	0.0989171322503712
SOTOS SYNDROME 2	0.000995025	0.0989171322503712
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.000995025	0.0989171322503712
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.000995025	0.0989171322503712
PURE MITOCHONDRIAL MYOPATHY	0.000995025	0.0989171322503712
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.000995025	0.0989171322503712
FEMORAL-FACIAL SYNDROME	0.000995025	0.0989171322503712
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000995025	0.0989171322503712
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.000995025	0.0989171322503712
ATELOSTEOGENESIS TYPE I	0.000995025	0.0989171322503712
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.0989171322503712
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.000995025	0.0989171322503712
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.05382338617206977
HOLOPROSENCEPHALY 1; HPE1	0.000541419	0.05382338617206977
DISTAL TRISOMY 15Q	0.000541419	0.05382338617206977
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.05382338617206977
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.05382338617206977
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000541419	0.05382338617206977
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.05382338617206977
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.05382338617206977
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000541419	0.05382338617206977
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.05382338617206977
MOSAIC TRISOMY 14	0.000541419	0.05382338617206977
KEUTEL SYNDROME	0.000541419	0.05382338617206977
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.05382338617206977
CHROMOSOME 1P35 DELETION SYNDROME	0.000541419	0.05382338617206977
OHDO SYNDROME	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.05382338617206977
HARTNUP DISORDER	0.000541419	0.05382338617206977
FETAL GAUCHER DISEASE	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.05382338617206977
TAY-SACHS DISEASE	0.000541419	0.05382338617206977
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.05382338617206977
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.05382338617206977
FREE SIALIC ACID STORAGE DISEASE	0.000541419	0.05382338617206977
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000541419	0.05382338617206977
LANDAU-KLEFFNER SYNDROME	0.000541419	0.05382338617206977
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000541419	0.05382338617206977
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.05382338617206977
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000541419	0.05382338617206977
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000541419	0.05382338617206977
KRABBE DISEASE	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000541419	0.05382338617206977
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.000541419	0.05382338617206977
KIFAFA SEIZURE DISORDER	0.000541419	0.05382338617206977
KEUTEL SYNDROME; KTLS	0.000541419	0.05382338617206977
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.05382338617206977
KETOADIPICACIDURIA	0.000541419	0.05382338617206977
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.05382338617206977
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000541419	0.05382338617206977
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.05382338617206977
VICI SYNDROME; VICIS	0.000541419	0.05382338617206977
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000541419	0.05382338617206977
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.05382338617206977
47,XYY SYNDROME	0.000541419	0.05382338617206977
GRISCELLI SYNDROME TYPE 1	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000541419	0.05382338617206977
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.05382338617206977
HYPER-BETA-ALANINEMIA	0.000541419	0.05382338617206977
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.05382338617206977
DYSEQUILIBRIUM SYNDROME	0.000541419	0.05382338617206977
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.05382338617206977
HYPERLYSINEMIA, TYPE I	0.000541419	0.05382338617206977
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.05382338617206977
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000541419	0.05382338617206977
SCHIZENCEPHALY	0.000541419	0.05382338617206977
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.05382338617206977
MACDERMOT-WINTER SYNDROME	0.000541419	0.05382338617206977
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.05382338617206977
SANDHOFF DISEASE	0.000541419	0.05382338617206977
HYPERPROLINEMIA, TYPE I	0.000541419	0.05382338617206977
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.05382338617206977
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.05382338617206977
HYPERPROLINEMIA, TYPE II	0.000541419	0.05382338617206977
GRISCELLI SYNDROME TYPE 2	0.000541419	0.05382338617206977
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000541419	0.05382338617206977
ANGELMAN SYNDROME	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.05382338617206977
PSEUDO-TORCH SYNDROME 2	0.000541419	0.05382338617206977
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.05382338617206977
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.05382338617206977
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000541419	0.05382338617206977
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000541419	0.05382338617206977
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.05382338617206977
PEHO SYNDROME; PEHO	0.000541419	0.05382338617206977
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.05382338617206977
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.05382338617206977
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.05382338617206977
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.05382338617206977
MOGS-CDG	0.000541419	0.05382338617206977
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.05382338617206977
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000541419	0.05382338617206977
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000541419	0.05382338617206977
ELEJALDE DISEASE	0.000541419	0.05382338617206977
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000541419	0.05382338617206977
NEURAMINIDASE DEFICIENCY	0.000541419	0.05382338617206977
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.05382338617206977
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.05382338617206977
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.05382338617206977
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.05382338617206977
LEIGH SYNDROME; LS	0.000541419	0.05382338617206977
EAST SYNDROME	0.000541419	0.05382338617206977
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000541419	0.05382338617206977
ACROCARDIOFACIAL SYNDROME	0.000541419	0.05382338617206977
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.05382338617206977
CEDNIK SYNDROME	0.000541419	0.05382338617206977
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.05382338617206977
LISSENCEPHALY 8; LIS8	0.000541419	0.05382338617206977
CRIGLER-NAJJAR SYNDROME	0.000541419	0.05382338617206977
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.05382338617206977
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000541419	0.05382338617206977
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.05382338617206977
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000541419	0.05382338617206977
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000541419	0.05382338617206977
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.05382338617206977
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.05382338617206977
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000541419	0.05382338617206977
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05382338617206977
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.05382338617206977
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.05382338617206977
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.05382338617206977
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000541419	0.05382338617206977
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.05382338617206977
PYRUVATE CARBOXYLASE DEFICIENCY	0.000541419	0.05382338617206977
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.05382338617206977
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000541419	0.05382338617206977
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.05382338617206977
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.05382338617206977
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.05382338617206977
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000541419	0.05382338617206977
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.05382338617206977
AL KAISSI SYNDROME; ALKAS	0.000541419	0.05382338617206977
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.05382338617206977
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.000541419	0.05382338617206977
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000541419	0.05382338617206977
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000541419	0.05382338617206977
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000541419	0.05382338617206977
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000541419	0.05382338617206977
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000541419	0.05382338617206977
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.05382338617206977
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000541419	0.05382338617206977
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.05382338617206977
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.05382338617206977
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000541419	0.05382338617206977
ALG3-CDG	0.000541419	0.05382338617206977
DPM1-CDG	0.000541419	0.05382338617206977
MPDU1-CDG	0.000541419	0.05382338617206977
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000541419	0.05382338617206977
ALG2-CDG	0.000541419	0.05382338617206977
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.05382338617206977
ALG9-CDG	0.000541419	0.05382338617206977
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.05382338617206977
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.05382338617206977
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000541419	0.05382338617206977
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.05382338617206977
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000541419	0.05382338617206977
FRONTAL ENCEPHALOCELE	0.000541419	0.05382338617206977
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.05382338617206977
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000541419	0.05382338617206977
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000541419	0.05382338617206977
INFANTILE REFSUM DISEASE	0.000541419	0.05382338617206977
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.05382338617206977
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.05382338617206977
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000541419	0.05382338617206977
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.05382338617206977
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000541419	0.05382338617206977
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000541419	0.05382338617206977
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000541419	0.05382338617206977
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.05382338617206977
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.05382338617206977
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.05382338617206977
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.05382338617206977
JOUBERT SYNDROME 30; JBTS30	0.000541419	0.05382338617206977
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000541419	0.05382338617206977
DEND SYNDROME	0.000541419	0.05382338617206977
EPISODIC ATAXIA TYPE 3	0.000541419	0.05382338617206977
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.05382338617206977
PERRAULT SYNDROME 3	0.000541419	0.05382338617206977
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.05382338617206977
NON-DISTAL MONOSOMY 20Q	0.000541419	0.05382338617206977
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000541419	0.05382338617206977
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.05382338617206977
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.05382338617206977
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.05382338617206977
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.05382338617206977
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000541419	0.05382338617206977
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000541419	0.05382338617206977
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.05382338617206977
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.05382338617206977
DISTAL MONOSOMY 19P13.3	0.000541419	0.05382338617206977
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.05382338617206977
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000541419	0.05382338617206977
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.05382338617206977
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000541419	0.05382338617206977
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.05382338617206977
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.05382338617206977
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.05382338617206977
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.05382338617206977
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.05382338617206977
BOWEN-CONRADI SYNDROME	0.000541419	0.05382338617206977
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.05382338617206977
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.05382338617206977
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.05382338617206977
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.05382338617206977
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.05382338617206977
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000541419	0.05382338617206977
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.05382338617206977
PARTINGTON SYNDROME	0.000541419	0.05382338617206977
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.05382338617206977
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.05382338617206977
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.05382338617206977
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.05382338617206977
TUBEROUS SCLEROSIS-1	0.000541419	0.05382338617206977
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.05382338617206977
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.05382338617206977
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000541419	0.05382338617206977
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.05382338617206977
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.05382338617206977
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000541419	0.05382338617206977
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.05382338617206977
17Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.05382338617206977
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.05382338617206977
COG8-CDG	0.000541419	0.05382338617206977
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.05382338617206977
STURGE-WEBER SYNDROME	0.000541419	0.05382338617206977
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.05382338617206977
PITUITARY STALK INTERRUPTION SYNDROME	0.000541419	0.05382338617206977
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.05382338617206977
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.05382338617206977
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.05382338617206977
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.05382338617206977
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000541419	0.05382338617206977
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.05382338617206977
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.05382338617206977
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000541419	0.05382338617206977
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000541419	0.05382338617206977
PAPILLORENAL SYNDROME	0.000541419	0.05382338617206977
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.05382338617206977
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.05382338617206977
ROMANO-WARD SYNDROME	0.000541419	0.05382338617206977
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000541419	0.05382338617206977
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.05382338617206977
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.05382338617206977
SECONDARY SYRINGOMYELIA	0.000541419	0.05382338617206977
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.05382338617206977
ADENYLOSUCCINASE DEFICIENCY	0.000541419	0.05382338617206977
ADAMS-OLIVER SYNDROME 1; AOS1	0.000541419	0.05382338617206977
15Q13.3 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.05382338617206977
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.05382338617206977
2Q33.1 DELETION SYNDROME	0.000541419	0.05382338617206977
ATAXIA-TELANGIECTASIA	0.000541419	0.05382338617206977
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.05382338617206977
POTOCKI-SHAFFER SYNDROME	0.000541419	0.05382338617206977
1P36 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.05382338617206977
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000541419	0.05382338617206977
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.05382338617206977
BETA-MANNOSIDOSIS	0.000541419	0.05382338617206977
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.05382338617206977
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.05382338617206977
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.05382338617206977
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.05382338617206977
KBG SYNDROME	0.000541419	0.05382338617206977
PALLISTER-HALL SYNDROME	0.000541419	0.05382338617206977
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.05382338617206977
ADRENOMYODYSTROPHY	0.000541419	0.05382338617206977
HUNTINGTON DISEASE; HD	0.000541419	0.05382338617206977
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.05382338617206977
MYHRE SYNDROME	0.000541419	0.05382338617206977
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.05382338617206977
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.05382338617206977
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.05382338617206977
SPINOCEREBELLAR ATAXIA TYPE 13	0.000541419	0.05382338617206977
EPILEPSY, READING	0.000541419	0.05382338617206977
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.05382338617206977
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000541419	0.05382338617206977
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.05382338617206977
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.05382338617206977
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.05382338617206977
DARIER-WHITE DISEASE; DAR	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000541419	0.05382338617206977
CROUZON SYNDROME	0.000541419	0.05382338617206977
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.05382338617206977
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000541419	0.05382338617206977
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000541419	0.05382338617206977
DYSOSTEOSCLEROSIS	0.000541419	0.05382338617206977
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.05382338617206977
TRIPLE A SYNDROME	0.000541419	0.05382338617206977
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.05382338617206977
SIALIDOSIS TYPE 2	0.000541419	0.05382338617206977
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000541419	0.05382338617206977
2P21 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
HYPEREKPLEXIA 4; HKPX4	0.000541419	0.05382338617206977
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.05382338617206977
ONDINE SYNDROME	0.000541419	0.05382338617206977
DISTAL MONOSOMY 3P	0.000541419	0.05382338617206977
EPILEPSY-TELANGIECTASIA	0.000541419	0.05382338617206977
2Q24 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000541419	0.05382338617206977
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000541419	0.05382338617206977
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000541419	0.05382338617206977
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000541419	0.05382338617206977
CROME SYNDROME	0.000541419	0.05382338617206977
WALKER-WARBURG SYNDROME	0.000541419	0.05382338617206977
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.05382338617206977
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.05382338617206977
DISTAL MONOSOMY 15Q	0.000541419	0.05382338617206977
ARGININEMIA	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.05382338617206977
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.05382338617206977
MEHMO SYNDROME	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.05382338617206977
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.05382338617206977
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.05382338617206977
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.05382338617206977
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000541419	0.05382338617206977
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.05382338617206977
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.05382338617206977
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.05382338617206977
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.05382338617206977
FRYNS SYNDROME; FRNS	0.000541419	0.05382338617206977
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.05382338617206977
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.05382338617206977
FOUNTAIN SYNDROME	0.000541419	0.05382338617206977
FOLATE MALABSORPTION, HEREDITARY	0.000541419	0.05382338617206977
DPAGT1-CDG	0.000541419	0.05382338617206977
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.05382338617206977
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.05382338617206977
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.05382338617206977
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.05382338617206977
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.05382338617206977
PFEIFFER SYNDROME TYPE 2	0.000541419	0.05382338617206977
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.05382338617206977
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.05382338617206977
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.05382338617206977
AUTISM	0.000541419	0.05382338617206977
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.05382338617206977
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000541419	0.05382338617206977
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.05382338617206977
ARGININOSUCCINIC ACIDURIA	0.000541419	0.05382338617206977
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000541419	0.05382338617206977
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.05382338617206977
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.05382338617206977
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.05382338617206977
PFEIFFER SYNDROME TYPE 3	0.000541419	0.05382338617206977
COACH SYNDROME	0.000541419	0.05382338617206977
VICI SYNDROME	0.000541419	0.05382338617206977
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.05382338617206977
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.05382338617206977
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.05382338617206977
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000541419	0.05382338617206977
ALEXANDER DISEASE	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000541419	0.05382338617206977
RING CHROMOSOME 22 SYNDROME	0.000541419	0.05382338617206977
RING CHROMOSOME 10 SYNDROME	0.000541419	0.05382338617206977
XQ21 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000541419	0.05382338617206977
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.05382338617206977
BANGSTAD SYNDROME	0.000541419	0.05382338617206977
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.05382338617206977
CITRULLINEMIA, CLASSIC	0.000541419	0.05382338617206977
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.05382338617206977
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.05382338617206977
GRISCELLI SYNDROME, TYPE 1	0.000541419	0.05382338617206977
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.05382338617206977
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.05382338617206977
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.05382338617206977
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.05382338617206977
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.05382338617206977
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.000541419	0.05382338617206977
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.05382338617206977
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.05382338617206977
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.05382338617206977
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.05382338617206977
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.05382338617206977
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.05382338617206977
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.05382338617206977
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.05382338617206977
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.05382338617206977
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.05382338617206977
DIAMINOPENTANURIA	0.000541419	0.05382338617206977
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.05382338617206977
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.05382338617206977
INFANTILE LIVER FAILURE SYNDROME 1	0.000541419	0.05382338617206977
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000541419	0.05382338617206977
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.05382338617206977
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.05382338617206977
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000541419	0.05382338617206977
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.05382338617206977
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.05382338617206977
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000541419	0.05382338617206977
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.05382338617206977
OROFACIODIGITAL SYNDROME TYPE 6	0.000541419	0.05382338617206977
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.05382338617206977
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.05382338617206977
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.05382338617206977
CHROMOSOME 10Q26 DELETION SYNDROME	0.000541419	0.05382338617206977
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.05382338617206977
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.05382338617206977
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.05382338617206977
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000541419	0.05382338617206977
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.05382338617206977
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000541419	0.05382338617206977
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.05382338617206977
20Q11.2 MICRODUPLICATION SYNDROME	0.000541419	0.05382338617206977
DISTAL MONOSOMY 1Q	0.000541419	0.05382338617206977
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.05382338617206977
SCHINDLER DISEASE, TYPE I	0.000541419	0.05382338617206977
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.05382338617206977
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.05382338617206977
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.05382338617206977
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000541419	0.05382338617206977
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.05382338617206977
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000541419	0.05382338617206977
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000541419	0.05382338617206977
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.05382338617206977
HOLOPROSENCEPHALY 7	0.000541419	0.05382338617206977
LISSENCEPHALY 5; LIS5	0.000541419	0.05382338617206977
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.05382338617206977
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.05382338617206977
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.05382338617206977
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000541419	0.05382338617206977
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.05382338617206977
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.05382338617206977
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.05382338617206977
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.05382338617206977
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.05382338617206977
WILSON-TURNER SYNDROME	0.000541419	0.05382338617206977
WORSTER-DROUGHT SYNDROME	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.05382338617206977
CHIME SYNDROME	0.000541419	0.05382338617206977
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.05382338617206977
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000541419	0.05382338617206977
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.05382338617206977
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.05382338617206977
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.05382338617206977
GALACTOSIALIDOSIS	0.000541419	0.05382338617206977
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.05382338617206977
GALACTOSEMIA	0.000541419	0.05382338617206977
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.05382338617206977
THANATOPHORIC DYSPLASIA	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.05382338617206977
ALZHEIMER DISEASE 3; AD	0.000541419	0.05382338617206977
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.05382338617206977
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.05382338617206977
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.05382338617206977
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000541419	0.05382338617206977
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.05382338617206977
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000541419	0.05382338617206977
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000541419	0.05382338617206977
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.05382338617206977
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.05382338617206977
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.05382338617206977
MEND SYNDROME	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000541419	0.05382338617206977
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000541419	0.05382338617206977
NIEMANN-PICK DISEASE, TYPE C2	0.000541419	0.05382338617206977
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.05382338617206977
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000541419	0.05382338617206977
LISSENCEPHALY 1; LIS1	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.05382338617206977
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.05382338617206977
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.05382338617206977
LATHOSTEROLOSIS	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000541419	0.05382338617206977
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.05382338617206977
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000541419	0.05382338617206977
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.05382338617206977
COG5-CDG	0.000541419	0.05382338617206977
CHROMOSOME 5Q12 DELETION SYNDROME	0.000541419	0.05382338617206977
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.05382338617206977
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.05382338617206977
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000541419	0.05382338617206977
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.05382338617206977
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000541419	0.05382338617206977
XP21 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000541419	0.05382338617206977
21Q22.11Q22.12 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000541419	0.05382338617206977
20P12.3 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.05382338617206977
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000541419	0.05382338617206977
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.05382338617206977
GRISCELLI SYNDROME	0.000541419	0.05382338617206977
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000541419	0.05382338617206977
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000541419	0.05382338617206977
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000541419	0.05382338617206977
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.05382338617206977
HSD10 DISEASE	0.000541419	0.05382338617206977
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000541419	0.05382338617206977
TRISOMY X	0.000541419	0.05382338617206977
FILIPPI SYNDROME; FLPIS	0.000541419	0.05382338617206977
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.05382338617206977
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000541419	0.05382338617206977
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.05382338617206977
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000541419	0.05382338617206977
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.05382338617206977
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000541419	0.05382338617206977
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.05382338617206977
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.05382338617206977
PORENCEPHALY	0.000541419	0.05382338617206977
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.05382338617206977
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.05382338617206977
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.05382338617206977
TUBEROUS SCLEROSIS 2; TSC2	0.000541419	0.05382338617206977
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.05382338617206977
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.05382338617206977
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.05382338617206977
GABA-TRANSAMINASE DEFICIENCY	0.000541419	0.05382338617206977
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.05382338617206977
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.05382338617206977
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.05382338617206977
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000541419	0.05382338617206977
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000541419	0.05382338617206977
20P13 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.05382338617206977
11P15.4 MICRODUPLICATION SYNDROME	0.000541419	0.05382338617206977
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.05382338617206977
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.05382338617206977
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.05382338617206977
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000541419	0.05382338617206977
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000541419	0.05382338617206977
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.05382338617206977
ISOLATED BILIARY ATRESIA	0.000541419	0.05382338617206977
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.05382338617206977
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.05382338617206977
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.05382338617206977
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000541419	0.05382338617206977
LISSENCEPHALY 4	0.000541419	0.05382338617206977
ADAMS-OLIVER SYNDROME 2; AOS2	0.000541419	0.05382338617206977
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.05382338617206977
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.000541419	0.05382338617206977
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.05382338617206977
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000541419	0.05382338617206977
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.05382338617206977
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.05382338617206977
RAMON SYNDROME	0.000541419	0.05382338617206977
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.05382338617206977
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000541419	0.05382338617206977
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.05382338617206977
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000541419	0.05382338617206977
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.05382338617206977
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.05382338617206977
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000541419	0.05382338617206977
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000541419	0.05382338617206977
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000541419	0.05382338617206977
ISOVALERIC ACIDEMIA	0.000541419	0.05382338617206977
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000541419	0.05382338617206977
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.05382338617206977
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000541419	0.05382338617206977
TETRASOMY 5P	0.000541419	0.05382338617206977
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.05382338617206977
STURGE-WEBER SYNDROME	0.000541419	0.05382338617206977
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.05382338617206977
LISSENCEPHALY 3; LIS3	0.000541419	0.05382338617206977
THYROCEREBRORENAL SYNDROME	0.000541419	0.05382338617206977
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.05382338617206977
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000541419	0.05382338617206977
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000541419	0.05382338617206977
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.05382338617206977
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000541419	0.05382338617206977
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.05382338617206977
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000541419	0.05382338617206977
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.05382338617206977
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.05382338617206977
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.05382338617206977
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.05382338617206977
CONGENITAL RUBELLA SYNDROME	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.05382338617206977
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.05382338617206977
MEVALONIC ACIDURIA	0.000541419	0.05382338617206977
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.05382338617206977
RENPENNING SYNDROME	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.05382338617206977
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.05382338617206977
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000541419	0.05382338617206977
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000541419	0.05382338617206977
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000541419	0.05382338617206977
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000541419	0.05382338617206977
SRD5A3-CDG	0.000541419	0.05382338617206977
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000541419	0.05382338617206977
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000541419	0.05382338617206977
FILIPPI SYNDROME	0.000541419	0.05382338617206977
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.05382338617206977
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000541419	0.05382338617206977
SECKEL SYNDROME 7; SCKL7	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000541419	0.05382338617206977
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.05382338617206977
GLASS SYNDROME	0.000541419	0.05382338617206977
MOYNAHAN SYNDROME	0.000541419	0.05382338617206977
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.05382338617206977
XQ25 DUPLICATION SYNDROME	0.000541419	0.05382338617206977
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.05382338617206977
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000541419	0.05382338617206977
IMMUNODEFICIENCY 47	0.000541419	0.05382338617206977
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000541419	0.05382338617206977
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.05382338617206977
LIPOID PROTEINOSIS	0.000541419	0.05382338617206977
MILLER-DIEKER SYNDROME	0.000541419	0.05382338617206977
MEND SYNDROME; MEND	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000541419	0.05382338617206977
MATERNAL PHENYLKETONURIA	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000541419	0.05382338617206977
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.05382338617206977
HYDRANENCEPHALY	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000541419	0.05382338617206977
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 88	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 90	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.05382338617206977
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.05382338617206977
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.05382338617206977
CONGENITAL HYDROCEPHALUS	0.000541419	0.05382338617206977
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 103	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.05382338617206977
MENKES DISEASE	0.000541419	0.05382338617206977
INCONTINENTIA PIGMENTI; IP	0.000541419	0.05382338617206977
LEIGH SYNDROME	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.05382338617206977
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.05382338617206977
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.05382338617206977
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.05382338617206977
HHHH SYNDROME	0.000541419	0.05382338617206977
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.05382338617206977
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000541419	0.05382338617206977
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.05382338617206977
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.05382338617206977
MAPLE SYRUP URINE DISEASE	0.000541419	0.05382338617206977
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.05382338617206977
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.05382338617206977
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.05382338617206977
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.05382338617206977
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000541419	0.05382338617206977
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.05382338617206977
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000541419	0.05382338617206977
LUSCAN-LUMISH SYNDROME; LLS	0.000541419	0.05382338617206977
XQ25 MICRODUPLICATION SYNDROME	0.000541419	0.05382338617206977
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.05382338617206977
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000541419	0.05382338617206977
SHUKLA-VERNON SYNDROME; SHUVER	0.000541419	0.05382338617206977
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000541419	0.05382338617206977
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.05382338617206977
MOYAMOYA DISEASE	0.000541419	0.05382338617206977
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000541419	0.05382338617206977
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000541419	0.05382338617206977
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.05382338617206977
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000541419	0.05382338617206977
ADRENOLEUKODYSTROPHY	0.000541419	0.05382338617206977
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000541419	0.05382338617206977
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.05382338617206977
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.05382338617206977
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.05382338617206977
XYLOSIDASE DEFICIENCY	0.000541419	0.05382338617206977
ALSTRÖM SYNDROME	0.000541419	0.05382338617206977
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000541419	0.05382338617206977
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.05382338617206977
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.05382338617206977
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.05382338617206977
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.05382338617206977
RECURRENT ACUTE PANCREATITIS	0.000541419	0.05382338617206977
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.05382338617206977
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000541419	0.05382338617206977
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.05382338617206977
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.05382338617206977
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000541419	0.05382338617206977
LEBER CONGENITAL AMAUROSIS	0.000541419	0.05382338617206977
IMMUNODEFICIENCY 49; IMD49	0.000541419	0.05382338617206977
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.05382338617206977
THYROCEREBRORETINAL SYNDROME	0.000541419	0.05382338617206977
THREONINEMIA	0.000541419	0.05382338617206977
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000541419	0.05382338617206977
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000541419	0.05382338617206977
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.05382338617206977
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.05382338617206977
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000541419	0.05382338617206977
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05382338617206977
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.05382338617206977
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.05382338617206977
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.05382338617206977
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000541419	0.05382338617206977
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.05382338617206977
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.05382338617206977
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.05382338617206977
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000541419	0.05382338617206977
HENNEKAM SYNDROME	0.000541419	0.05382338617206977
MULTIPLE SULFATASE DEFICIENCY	0.000541419	0.05382338617206977
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000541419	0.05382338617206977
MYASTHENIA GRAVIS	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000541419	0.05382338617206977
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.05382338617206977
CYSTATHIONINURIA	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 72	0.000541419	0.05382338617206977
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.05382338617206977
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.05382338617206977
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.05382338617206977
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.05382338617206977
MUENKE SYNDROME	0.000541419	0.05382338617206977
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.05382338617206977
NEONATAL ADRENOLEUKODYSTROPHY	0.000541419	0.05382338617206977
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.05382338617206977
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.05382338617206977
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000541419	0.05382338617206977
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000541419	0.05382338617206977
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000541419	0.05382338617206977
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.05382338617206977
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000541419	0.05382338617206977
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.05382338617206977
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.05382338617206977
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000541419	0.05382338617206977
8P23.1 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
6Q25 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.05382338617206977
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000541419	0.05382338617206977
3Q29 MICRODUPLICATION SYNDROME	0.000541419	0.05382338617206977
GRACILE BONE DYSPLASIA; GCLEB	0.000541419	0.05382338617206977
CATEL-MANZKE SYNDROME; CATMANS	0.000541419	0.05382338617206977
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.05382338617206977
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000541419	0.05382338617206977
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.05382338617206977
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.05382338617206977
AICA-RIBOSIDURIA	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000541419	0.05382338617206977
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.05382338617206977
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000541419	0.05382338617206977
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000541419	0.05382338617206977
DYSTONIA-APHONIA SYNDROME	0.000541419	0.05382338617206977
MOMO SYNDROME	0.000541419	0.05382338617206977
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000541419	0.05382338617206977
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.05382338617206977
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000541419	0.05382338617206977
HYPERPROLINEMIA TYPE 1	0.000541419	0.05382338617206977
KUFOR-RAKEB SYNDROME	0.000541419	0.05382338617206977
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.05382338617206977
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000541419	0.05382338617206977
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.05382338617206977
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.05382338617206977
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000541419	0.05382338617206977
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.05382338617206977
PHACE SYNDROME	0.000541419	0.05382338617206977
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.05382338617206977
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.05382338617206977
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.05382338617206977
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.05382338617206977
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000541419	0.05382338617206977
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.05382338617206977
SALLA DISEASE	0.000541419	0.05382338617206977
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.05382338617206977
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.05382338617206977
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.05382338617206977
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000541419	0.05382338617206977
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.05382338617206977
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05382338617206977
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.05382338617206977
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000541419	0.05382338617206977
15Q11Q13 MICRODUPLICATION SYNDROME	0.000541419	0.05382338617206977
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.05382338617206977
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.05382338617206977
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.000541419	0.05382338617206977
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05382338617206977
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.05382338617206977
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.05382338617206977
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000541419	0.05382338617206977
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000541419	0.05382338617206977
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000541419	0.05382338617206977
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000541419	0.05382338617206977
PELIZAEUS-MERZBACHER DISEASE	0.000541419	0.05382338617206977
WAISMAN SYNDROME; WSMN	0.000541419	0.05382338617206977
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.05382338617206977
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.05382338617206977
DUANE RETRACTION SYNDROME	0.000541419	0.05382338617206977
SANJAD-SAKATI SYNDROME	0.000541419	0.05382338617206977
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.05382338617206977
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.05382338617206977
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.05382338617206977
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.05382338617206977
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000541419	0.05382338617206977
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.05382338617206977
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.05382338617206977
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.05382338617206977
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.05382338617206977
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.05382338617206977
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.05382338617206977
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.05382338617206977
LATHOSTEROLOSIS	0.000541419	0.05382338617206977
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.05382338617206977
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000541419	0.05382338617206977
JUVENILE HUNTINGTON DISEASE	0.000541419	0.05382338617206977
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.05382338617206977
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.05382338617206977
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.05382338617206977
CITRULLINEMIA TYPE II	0.000541419	0.05382338617206977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.05382338617206977
POTOCKI-SHAFFER SYNDROME	0.000541419	0.05382338617206977
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.05382338617206977
GURRIERI SYNDROME	0.000541419	0.05382338617206977
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000541419	0.05382338617206977
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.05382338617206977
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000541419	0.05382338617206977
SLC39A8-CDG	0.000541419	0.05382338617206977
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.05382338617206977
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.05382338617206977
LOWRY-MACLEAN SYNDROME	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000541419	0.05382338617206977
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.05382338617206977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000541419	0.05382338617206977
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.05382338617206977
BAND HETEROTOPIA; BH	0.000541419	0.05382338617206977
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.05382338617206977
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.05382338617206977
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.05382338617206977
